{"Pages":[{"Width":37.205,"Height":48.898,"HLines":[{"x":9.963,"y":9.062,"w":1.5,"l":24.459,"oc":"#838f97","dsh":1},{"x":2.54,"y":47.034,"w":0.45,"l":32.125,"oc":"#000000"}],"VLines":[{"x":9.244,"y":9.749,"w":1.5,"l":36.075,"oc":"#838f97","dsh":1}],"Fills":[{"x":23.91,"y":0.537,"w":10.734,"h":1.113,"oc":"#838f97"},{"x":0,"y":-0.531,"w":37.736,"h":1.152,"oc":"#838f97"},{"x":21.271,"y":4.535,"w":1.383,"h":2.223,"oc":"#000000"},{"x":23.211,"y":4.535,"w":1.194,"h":2.223,"oc":"#000000"},{"x":25.086,"y":4.535,"w":1.215,"h":2.223,"oc":"#000000"},{"x":29.664,"y":4.535,"w":1.383,"h":2.223,"oc":"#000000"},{"x":31.339,"y":4.535,"w":1.333,"h":2.223,"oc":"#000000"},{"x":33.111,"y":4.488,"w":1.398,"h":2.317,"oc":"#000000"},{"x":26.554,"y":4.279,"w":2.762,"h":2.762,"oc":"#ed1c24"},{"x":2.657,"y":4.51,"w":1.337,"h":2.259,"oc":"#000000"},{"x":4.569,"y":4.51,"w":1.879,"h":2.259,"oc":"#000000"},{"x":7.202,"y":4.539,"w":0.14,"h":2.201,"oc":"#000000"},{"x":8.16,"y":4.539,"w":1.051,"h":2.2,"oc":"#000000"},{"x":9.984,"y":4.51,"w":1.987,"h":2.303,"oc":"#000000"},{"x":12.57,"y":4.539,"w":1.278,"h":2.201,"oc":"#000000"},{"x":14.447,"y":4.539,"w":0.14,"h":2.201,"oc":"#000000"},{"x":15.404,"y":4.539,"w":0.887,"h":2.2,"oc":"#000000"},{"x":17.045,"y":4.539,"w":0.14,"h":2.201,"oc":"#000000"},{"x":17.871,"y":4.51,"w":1.879,"h":2.259,"oc":"#000000"}],"Texts":[{"x":24.108,"y":0.6419999999999999,"w":15.543,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports","S":-1,"TS":[0,13.25,0,0]}]},{"x":5.623,"y":9.547,"w":2.6310000000000002,"oc":"#f5821f","sw":0.26821875,"A":"left","R":[{"T":"opeN","S":-1,"TS":[0,22,1,0]}]},{"x":9.477,"y":9.963,"w":14.816,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Four-Year%20Outcome%20of%20Aflibercept%20","S":-1,"TS":[2,30,1,0]}]},{"x":9.477,"y":11.838,"w":12.589,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"for%20Neovascular%20Age-Related%20","S":-1,"TS":[0,30,1,0]}]},{"x":9.477,"y":13.713,"w":11.625,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Macular%20Degeneration%20and%20","S":-1,"TS":[2,30,1,0]}]},{"x":0.33699999999999997,"y":14.85,"w":10.638,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"Received%3A%2014%20August%202018","S":-1,"TS":[0,11.5,0,0]}]},{"x":9.477,"y":15.588999999999999,"w":14.733,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"polypoidal%20choroidal%20vasculopathy","S":-1,"TS":[2,30,1,0]}]},{"x":0.33699999999999997,"y":15.725000000000001,"w":10.914,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"Accepted%3A%207%20February%202019","S":-1,"TS":[0,11.5,0,0]}]},{"x":0.33699999999999997,"y":16.6,"w":8.972999999999999,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"Published%3A%20xx%20xx%20xxxx","S":-1,"TS":[0,11.5,0,0]}]},{"x":9.477,"y":16.963,"w":3.0989999999999998,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Keiichi%20","S":-1,"TS":[2,14,1,0]}]},{"x":11.388,"y":16.963,"w":7.004,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Nishikawa%2C%20Akio","S":-1,"TS":[2,14,1,0]}]},{"x":15.764,"y":16.963,"w":2.422,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20Oishi","S":-1,"TS":[2,14,1,0]}]},{"x":17.199,"y":16.963,"w":0.206,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20","S":10,"TS":[0,14,1,0]}]},{"x":17.777,"y":16.963,"w":4.833,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20%2C%20Masayuki","S":-1,"TS":[2,14,1,0]}]},{"x":20.695,"y":16.963,"w":0.206,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20","S":-1,"TS":[2,14,1,0]}]},{"x":20.797,"y":16.963,"w":2.107,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Hata","S":10,"TS":[0,14,1,0]}]},{"x":22.114,"y":16.963,"w":4.722,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%2C%20Masahiro%20","S":-1,"TS":[2,14,1,0]}]},{"x":25.038,"y":16.963,"w":3.133,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Miyake","S":-1,"TS":[2,14,1,0]}]},{"x":26.996,"y":16.963,"w":1.1,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%2C%20s","S":10,"TS":[0,14,1,0]}]},{"x":27.655,"y":16.963,"w":2.558,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"otaro%20","S":10,"TS":[0,14,1,0]}]},{"x":29.203,"y":16.963,"w":2.221,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"ooto","S":10,"TS":[0,14,1,0]}]},{"x":30.591,"y":16.963,"w":0.523,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%2C%20","S":10,"TS":[0,14,1,0]}]},{"x":9.477,"y":17.713,"w":2.418,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Kenji%20","S":-1,"TS":[2,14,1,0]}]},{"x":10.894,"y":17.713,"w":2.516,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Yama","S":10,"TS":[0,14,1,0]}]},{"x":12.423,"y":17.713,"w":2.137,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"shiro","S":-1,"TS":[2,14,1,0]}]},{"x":13.758,"y":17.713,"w":0.206,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20","S":10,"TS":[0,14,1,0]}]},{"x":14.336,"y":17.713,"w":4.242,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20%2C%20Manabu","S":-1,"TS":[2,14,1,0]}]},{"x":16.885,"y":17.713,"w":3.204,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20Miyata","S":-1,"TS":[2,14,1,0]}]},{"x":18.861,"y":17.713,"w":0.206,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20","S":10,"TS":[0,14,1,0]}]},{"x":19.439,"y":17.713,"w":3.813,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20%2C%20Hiroshi","S":-1,"TS":[2,14,1,0]}]},{"x":21.719,"y":17.713,"w":0.206,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20","S":-1,"TS":[2,14,1,0]}]},{"x":21.778,"y":17.713,"w":3.347,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"tamura","S":10,"TS":[0,14,1,0]}]},{"x":23.824,"y":17.713,"w":0.206,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20","S":10,"TS":[0,14,1,0]}]},{"x":24.402,"y":17.713,"w":3.596,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20%2C%20Naoko","S":-1,"TS":[2,14,1,0]}]},{"x":26.547,"y":17.713,"w":6.642,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20Ueda-Arakawa","S":-1,"TS":[2,14,1,0]}]},{"x":30.64,"y":17.713,"w":0.523,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%2C%20","S":10,"TS":[0,14,1,0]}]},{"x":9.478,"y":18.463,"w":2.9619999999999997,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Ayako%20","S":-1,"TS":[2,14,1,0]}]},{"x":11.236,"y":18.463,"w":4.424,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Takahashi","S":-1,"TS":[2,14,1,0]}]},{"x":13.955,"y":18.463,"w":1.908,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%2C%20Yu%20","S":10,"TS":[0,14,1,0]}]},{"x":15.019,"y":18.463,"w":9.462,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Kawashima%20%26%20Akitaka","S":-1,"TS":[2,14,1,0]}]},{"x":20.931,"y":18.463,"w":4.5520000000000005,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20Tsujikawa","S":-1,"TS":[2,14,1,0]}]},{"x":9.477,"y":19.713,"w":41.418,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Intravitreal%20injections%20of%20anti-vascular%20endothelial%20growth%20factor%20agents%20such%20as%20ranibizumab%20and%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.477,"y":20.4,"w":41.515,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"aflibercept%20are%20the%20first-line%20treatment%20for%20neovascular%20age-related%20macular%20degeneration%20(AMD).%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.477,"y":21.088,"w":43.786,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"However%2C%20data%20about%20long-term%20outcome%20in%20real-world%20clinical%20practice%20is%20scarce.%20We%20recruited%2098%20AMD%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.477,"y":21.775,"w":44.729,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"patients%20and%20investigated%20four-year%20visual%20outcome.%20During%20the%20four%20years%2C%2025%20patients%20dropped%20out.%20The%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.477,"y":22.462,"w":9.469999999999999,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"survivors%20received%207.0%20","S":-1,"TS":[2,12,1,0]}]},{"x":14.734,"y":22.462,"w":1.1,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C2%B1%20","S":-1,"TS":[2,12,1,0]}]},{"x":15.308,"y":22.462,"w":18.02,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"0.1%20injections%20during%20the%20first%20year%20and%208.0%20","S":-1,"TS":[2,12,1,0]}]},{"x":25.315,"y":22.462,"w":1.1,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C2%B1%20","S":-1,"TS":[2,12,1,0]}]},{"x":25.888,"y":22.462,"w":15.378,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"7.4%20injections%20in%20the%20following%20three%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.478,"y":23.15,"w":44.376,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"years.%20The%20logarithm%20of%20minimum%20angle%20of%20resolution%20(logMAR)%20at%20baseline%2C%20year%20one%2C%20and%20year%20four%20was%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.478,"y":23.837,"w":5.588,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"0.28%2C%200.14%20(P%20","S":-1,"TS":[2,12,1,0]}]},{"x":12.554,"y":23.837,"w":0.984,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D%20","S":-1,"TS":[2,12,1,0]}]},{"x":13.062,"y":23.837,"w":8.254999999999999,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"0.033)%2C%20and%200.22%20(P%20","S":-1,"TS":[2,12,1,0]}]},{"x":17.625,"y":23.837,"w":0.984,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D%20","S":-1,"TS":[2,12,1,0]}]},{"x":18.133,"y":23.837,"w":27.426,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"0.697)%2C%20respectively.%20The%20gain%20of%20vision%20was%20not%20different%20among%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.477,"y":24.524,"w":44.525,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"AMD%20subtypes%20(typical%20AMD%2C%20polypoidal%20choroidal%20vasculopathy%2C%20and%20retinal%20angiomatous%20proliferation%3B%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.477,"y":25.212,"w":0.807,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"p%20","S":9,"TS":[0,12,1,0]}]},{"x":9.886,"y":25.212,"w":0.984,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D%20","S":-1,"TS":[2,12,1,0]}]},{"x":10.394,"y":25.212,"w":40.833,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"0.513)%20Among%20the%20investigated%20factors%2C%20the%20presence%20of%20external%20limiting%20membrane%20(ELM)%2C%20the%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.477,"y":25.899,"w":44.044,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"absence%20of%20vitreoretinal%20adhesion%2C%20and%20thicker%20choroid%20at%20baseline%20were%20associated%20with%20better%20logMAR%20","S":-1,"TS":[2,12,1,0]}]},{"x":28.619,"y":26.397,"w":1.421,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%926","S":-1,"TS":[2,8.8499999,1,0]}]},{"x":9.477,"y":26.587,"w":15.32,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"values%20at%20year%20four%20(coefficient%20beta%20","S":-1,"TS":[2,12,1,0]}]},{"x":17.978,"y":26.587,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":-1,"TS":[2,12,1,0]}]},{"x":18.415,"y":26.587,"w":0.206,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20","S":9,"TS":[0,12,1,0]}]},{"x":18.486,"y":26.587,"w":8.574,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%920.388%2C%200.201%2C%20and%20","S":-1,"TS":[2,12,1,0]}]},{"x":23.275,"y":26.587,"w":4.418,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%920.001%3B%20P","S":-1,"TS":[2,12,1,0]}]},{"x":25.761,"y":26.587,"w":0.984,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20%3D","S":-1,"TS":[2,12,1,0]}]},{"x":26.258,"y":26.587,"w":2.079,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%207.34","S":-1,"TS":[2,12,1,0]}]},{"x":27.382,"y":26.587,"w":1.1,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%20%C3%97","S":-1,"TS":[2,12,1,0]}]},{"x":28.002,"y":26.587,"w":1.017,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%2010","S":-1,"TS":[2,12,1,0]}]},{"x":29.139,"y":26.588,"w":7.676,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"%3B%200.01%2C%20and%200.028%2C%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.477,"y":27.275,"w":43.49,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"respectively).%20In%20the%20present%20study%2C%20vision%20was%20retained%20at%20baseline%20level%20after%20the%20four-year%20treatment%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.477,"y":27.963,"w":42.716,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"with%20aflibercept.%20The%20status%20of%20ELM%2C%20vitreoretinal%20adhesion%2C%20and%20choroidal%20thickness%20were%20predictive%20","S":-1,"TS":[2,12,1,0]}]},{"x":9.477,"y":28.65,"w":9.543,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"factors%20for%20final%20vision.","S":-1,"TS":[2,12,1,0]}]},{"x":31.629,"y":30.428,"w":0.48,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"1","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":30.619,"w":44.419000000000004,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Age-related%20macular%20degeneration%20(AMD)%20is%20a%20leading%20cause%20of%20blindness%20in%20developed%20countries.%20Late-stage%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":31.244,"w":44.77,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"AMD%20is%20characterized%20by%20geographic%20atrophy%20and%20choroidal%20neovascularization%20(CNV).%20While%20geographic%20atro-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":31.869,"w":45.061,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"phy%20progresses%20gradually%2C%20CNV%20causes%20hemorrhage%20and%20exudative%20changes%20in%20the%20macula%2C%20leading%20to%20rapid%20vision%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":32.494,"w":45.121,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"loss.%20Indeed%2C%20CNV%20is%20responsible%20for%20more%20than%2080%20percent%20of%20severe%20visual%20loss%20or%20legal%20blindness%20in%20patients%20with%20","S":3,"TS":[0,12,0,0]}]},{"x":10.781,"y":32.928,"w":0.48,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":33.119,"w":2.5450000000000004,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"AMD.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":33.744,"w":43.659,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"While%20there%20is%20no%20established%20cure%20for%20geographic%20atrophy%2C%20CNV%20can%20be%20controlled%20with%20vascular%20endothelial%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":34.369,"w":44.78,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"growth%20factor%20(VEGF)%20inhibitors.%20The%20anti-VEGF%20agents%20inhibit%20CNV%20growth%20and%20fluid%20leakage%2C%20which%20enable%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":34.994,"w":44.843,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"visual%20improvement.%20However%2C%20the%20treatment%20has%20some%20drawbacks%2C%20including%20a%20need%20for%20frequent%20intravitreal%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":35.619,"w":44.754,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"injections%3B%20additionally%2C%20it%20is%20not%20easy%20to%20strictly%20continue%20this%20regimen%20in%20clinical%20practice.%20Thus%2C%20visual%20gain%20in%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":36.244,"w":45.087,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"the%20first%20year%20is%20generally%20favorable%2C%20but%20long-term%20outcome%20is%20not%20as%20promising.%20For%20example%2C%20HORIZON%20and%20a%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":36.869,"w":44.98,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"subsequent%20SEVEN-UP%20study%20showed%20that%20visual%20acuity%20improved%20during%20monthly%20ranibizumab%20treatment%20and%20","S":3,"TS":[0,12,0,0]}]},{"x":16.071,"y":37.303,"w":0.708,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"3%2C","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":16.337,"y":37.303,"w":0.48,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"4","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":37.494,"w":44.099000000000004,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"gradually%20declined%20thereafter.%20Another%20large%20clinical%20trial%2C%20CATT%2C%20reported%20five-year%20follow-up%20data%20showing%20","S":3,"TS":[0,12,0,0]}]},{"x":30.13,"y":37.928,"w":0.48,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"5","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":38.119,"w":37.376000000000005,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"similar%20results%3B%20after%20the%20release%20from%20the%20trial%20protocol%2C%20visual%20acuity%20dropped%20to%20baseline%20level.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":38.744,"w":43.477,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"While%20the%20above-mentioned%20studies%20used%20ranibizumab%20or%20bevacizumab%2C%20there%20are%20other%20treatment%20options%20","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":39.369,"w":45.034,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"available%2C%20such%20as%20pegaptanib%20and%20aflibercept.%20Particularly%2C%20aflibercept%20is%20potentially%20more%20effective%20because%20it%20also%20","S":3,"TS":[0,12,0,0]}]},{"x":29.25,"y":39.803,"w":0.48,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"6","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.478,"y":39.994,"w":44.665,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"blocks%20placental%20growth%20factor%2C%20has%20a%20higher%20affinity%20for%20VEGF%2C%20and%20has%20a%20longer%20half-life.%20In%20fact%2C%20two-monthly%20","S":3,"TS":[0,12,0,0]}]},{"x":27.894,"y":40.428,"w":0.708,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"7%2C","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":28.165,"y":40.428,"w":0.48,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"8","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.478,"y":40.619,"w":43.704,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"injections%20of%20aflibercept%20achieved%20visual%20gain%20identical%20to%20monthly%20ranibizumab.%20In%20addition%2C%20switching%20to%20","S":3,"TS":[0,12,0,0]}]},{"x":28.396,"y":41.053,"w":0.708,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"9%2C","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":28.655,"y":41.053,"w":0.96,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"10","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":41.244,"w":44.161,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"aflibercept%20in%20ranibizumab-refractory%20cases%20generally%20shows%20anatomical%20improvement.%20Thus%2C%20we%20predicted%20that%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":41.869,"w":29.462,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"aflibercept%20may%20yield%20better%20long-term%20visual%20outcomes%20than%20ranibizumab.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":44.677,"w":47.518,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"Department%20of%20Ophthalmology%20and%20Visual%20Sciences%2C%20Kyoto%20University%20Graduate%20School%20of%20Medicine%2C%20Kyoto%2C%20Japan.%20","S":-1,"TS":[0,11.5,0,0]}]},{"x":9.477,"y":45.301,"w":32.748999999999995,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"correspondence%20and%20requests%20for%20materials%20should%20be%20addressed%20to%20A.O.%20(email%3A%20","S":-1,"TS":[0,11.5,0,0]}]},{"x":26.698,"y":45.301,"w":11.097,"clr":35,"sw":0.32553125,"A":"left","R":[{"T":"aquio%40kuhp.kyoto-u.ac.jp","S":-1,"TS":[2,11.5,0,0]}]},{"x":32.585,"y":45.301,"w":0.3,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":")","S":-1,"TS":[0,11.5,0,0]}]},{"x":2.3,"y":47.015,"w":5.514,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"Scientific%20","S":-1,"TS":[0,11,0,0]}]},{"x":5.048,"y":47.015,"w":3.429,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"RepoR","S":-1,"TS":[0,11,1,0]}]},{"x":6.762,"y":47.015,"w":1.255,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"ts","S":-1,"TS":[0,11,1,0]}]},{"x":7.37,"y":47.015,"w":7.835999999999999,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20%20%20%20%20%20%20%20%20%20(2019)%209%3A3620%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.268,"y":47.015,"w":0.627,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.572,"y":47.015,"w":18.416,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"https%3A%2F%2Fdoi.org%2F10.1038%2Fs41598-019-39995-5","S":-1,"TS":[2,11,0,0]}]},{"x":34.135,"y":47.014,"w":0.448,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"1","S":-1,"TS":[0,13,0,0]}]}],"Fields":[],"Boxsets":[]},{"Width":37.205,"Height":48.898,"HLines":[{"x":2.54,"y":47.034,"w":0.45,"l":32.125,"oc":"#000000"},{"x":9.946,"y":28.405,"w":1.5,"l":24.594,"oc":"#838f97","dsh":1}],"VLines":[],"Fills":[{"x":-0.531,"y":-0.531,"w":37.736,"h":1.152,"oc":"#838f97"},{"x":23.912,"y":0.54,"w":10.734,"h":1.113,"oc":"#838f97"},{"x":-0.531,"y":-0.531,"w":37.736,"h":2.339,"oc":"#838f97"}],"Texts":[{"x":2.29,"y":0.6539999999999999,"w":15.863,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports%2F","S":-1,"TS":[0,13,0,0]}]},{"x":24.108,"y":0.6419999999999999,"w":15.543,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports","S":-1,"TS":[0,13.25,0,0]}]},{"x":9.477,"y":23.28,"w":3.708,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Figure%201.","S":9,"TS":[0,12,1,0]}]},{"x":11.538,"y":23.28,"w":37.989,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20The%20box%20and%20whisker%20plot%20shows%20number%20of%20aflibercept%20injections%20in%20eyes%20with%20neovascular%20age-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":23.905,"w":43.918,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"related%20macular%20degeneration.%20(Top)%20The%20patients%20received%20three%20monthly%20injections%20followed%20by%20two-monthly%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":24.53,"w":43.966,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"treatments%20in%20the%20first%20year%20(seven%20times).%20Thereafter%2C%20additional%20treatment%20was%20administered%20at%20the%20physicians%E2%80%99%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":25.155,"w":44.936,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"discretion.%20The%20mean%20number%20of%20injections%20was%20approximately%202.5%20in%20the%20following%20years.%20Frequency%20distribution%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":25.78,"w":44.988,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"of%20the%20number%20of%20injections%20is%20shown%20in%20bottom%20panel.%20The%20histogram%20shows%20bimodal%20distribution%3B%20some%20patients%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":26.405,"w":41.919,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"required%20almost%20no%20injections%20in%20the%20second%2C%20third%2C%20and%20fourth%20years%2C%20whereas%20others%20required%20continuous%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":27.03,"w":4.144,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"injections.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":29.031,"w":43.488,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"When%20considering%20long-term%20visual%20outcome%2C%20identifying%20predictive%20factors%20for%20good%20or%20poor%20vision%20is%20impor-","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":29.656,"w":44.633,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"tant.%20Because%20it%20is%20not%20easy%20to%20continue%20intensive%20treatment%20for%20all%20patients%2C%20identifying%20those%20at%20high-risk%20and%20","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":30.281,"w":37.472,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"investing%20resources%20for%20these%20patients%20would%20improve%20the%20visual%20outcome%20of%20the%20overall%20cohort.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":30.906,"w":43.677,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"In%20the%20present%20study%2C%20we%20investigated%20the%20four-year%20visual%20outcome%20of%20aflibercept%20treatment%20in%20patients%20with%20","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":31.531,"w":23.418,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"AMD%20and%20explored%20the%20factors%20associated%20with%20final%20vision.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":32.658,"w":3.814,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Methods","S":-1,"TS":[2,15,1,0]}]},{"x":9.477,"y":33.283,"w":6.126,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Study%20design.%20","S":-1,"TS":[2,14,1,0]}]},{"x":13.789,"y":33.283,"w":20.687,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Prospective%2C%20non-randomized%2C%20interventional%20study.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":33.908,"w":43.593,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"The%20study%20design%20was%20approved%20by%20the%20Institutional%20Review%20Board%20of%20Kyoto%20University%20Graduate%20School%20of%20","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":34.533,"w":44.955,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Medicine%2C%20and%20all%20study%20conduct%20adhered%20to%20the%20tenets%20of%20the%20Declaration%20of%20Helsinki.%20Each%20patient%20gave%20written%20","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":35.158,"w":20.606,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"informed%20consent%20for%20the%20participation%20in%20the%20study.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":36.285,"w":13.358,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Patients%20and%20study%20population.%20","S":-1,"TS":[2,14,1,0]}]},{"x":18.252,"y":36.285,"w":29.428,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"We%20included%20treatment-na%C3%AFve%20AMD%20patients%20between%20December%202012%20and%20","S":3,"TS":[0,12,0,0]}]},{"x":28.897,"y":36.719,"w":0.96,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"11","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":33.936,"y":36.719,"w":0.96,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"12","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":36.91,"w":43.453,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"December%202013%20at%20Kyoto%20University%20Hospital.%20We%20had%20already%20reported%20one-year%20results%2C%20causes%20of%20vision%20loss","S":3,"TS":[0,12,0,0]}]},{"x":34.287,"y":36.91,"w":0.455,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20","S":3,"TS":[0,12,0,0]}]},{"x":17.973,"y":37.344,"w":0.96,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"13","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.478,"y":37.535,"w":41.278,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"and%20recurrence%20rate%20in%20the%20second%20year.%20Thus%2C%20this%20is%20a%20consecutive%20study%20based%20on%20the%20previous%20research.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":38.16,"w":34.818999999999996,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"The%20inclusion%20criteria%20included%20an%20age%20older%20than%2050%20years%2C%20axial%20length%20less%20than%2026.5%20","S":3,"TS":[0,12,0,0]}]},{"x":29.732,"y":38.16,"w":8.591,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"mm%2C%20the%20presence%20of%20","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":38.785,"w":45.003,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"neovascular%20AMD%2C%20and%20the%20willingness%20to%20participate%20in%20the%20study.%20The%20exclusion%20criteria%20included%20any%20previous%20","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":39.41,"w":44.72,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"treatment%20of%20CNV%20and%20the%20presence%20of%20other%20retinal%20diseases%20such%20as%20angioid%20streaks%2C%20vitelliform%20macular%20dystro-","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":40.035,"w":45.384,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"phy%2C%20and%20retinal%20vein%20or%20artery%20occlusion.%20Those%20with%20chronic%20courses%20of%20AMD%2C%20indicated%20by%20disease%20history%20and%2For%20","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":40.66,"w":17.456,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"massive%20fibrotic%20lesions%2C%20were%20also%20excluded.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":41.787,"w":18.028000000000002,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Intervention%20and%20observation%20procedure.%20","S":-1,"TS":[2,14,1,0]}]},{"x":21.232,"y":41.787,"w":23.526000000000003,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Each%20participant%20underwent%20three%20monthly%20injections%20fol-","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":42.412,"w":45.068,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"lowed%20by%20four%20two-monthly%20injections%20of%20aflibercept%20in%20the%20first%20year.%20The%20first-year%20protocol%20was%20identical%20to%20that%20","S":3,"TS":[0,12,0,0]}]},{"x":15.953,"y":42.846,"w":0.708,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"7%2C","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":16.21,"y":42.846,"w":0.48,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"8","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.478,"y":43.037,"w":44.762,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"used%20in%20the%20VIEW%20I%2FII%20studies.%20After%20the%20first%20year%2C%20treatment%20was%20continued%20at%20the%20physicians%E2%80%99%20discretion.%20In%20most%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":43.662,"w":30.377,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"cases%2C%20treatment%20was%20administered%20on%20an%20as%20needed%20basis%20(pro%20re%20nata%2C%20PRN).","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":44.287,"w":43.498,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"As%20previously%20reported%2C%20we%20investigated%20optical%20coherence%20tomography%20images%20at%20baseline%20and%20at%20year%20one%E2%80%94","S":3,"TS":[0,12,0,0]}]},{"x":18.161,"y":44.721,"w":1,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"11","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":44.912,"w":43.859,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"when%20the%20fixed%20regimen%20was%20finished.%20Briefly%2C%20we%20measured%20central%20retinal%20thickness%2C%20subfoveal%20choroidal%20","S":3,"TS":[0,12,0,0]}]},{"x":2.3,"y":47.015,"w":5.514,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"Scientific%20","S":-1,"TS":[0,11,0,0]}]},{"x":5.048,"y":47.015,"w":3.429,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"RepoR","S":-1,"TS":[0,11,1,0]}]},{"x":6.762,"y":47.015,"w":1.255,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"ts","S":-1,"TS":[0,11,1,0]}]},{"x":7.37,"y":47.015,"w":7.835999999999999,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20%20%20%20%20%20%20%20%20%20(2019)%209%3A3620%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.268,"y":47.015,"w":0.627,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.572,"y":47.015,"w":18.416,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"https%3A%2F%2Fdoi.org%2F10.1038%2Fs41598-019-39995-5","S":-1,"TS":[2,11,0,0]}]},{"x":34.096,"y":47.014,"w":0.511,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,13,0,0]}]}],"Fields":[],"Boxsets":[]},{"Width":37.205,"Height":48.898,"HLines":[{"x":2.54,"y":47.034,"w":0.45,"l":32.125,"oc":"#000000"},{"x":9.946,"y":19.008,"w":1.5,"l":24.594,"oc":"#838f97","dsh":1},{"x":9.727,"y":2.914,"w":0.375,"l":10.523,"oc":"#000000"},{"x":9.727,"y":3.641,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":2.914,"w":0.375,"l":4.563,"oc":"#000000"},{"x":20.25,"y":3.641,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":2.914,"w":0.375,"l":2.808,"oc":"#000000"},{"x":24.813,"y":3.641,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":5.094,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":5.094,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":5.094,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":5.82,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":5.82,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":5.82,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":6.547,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":6.547,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":6.547,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":7.273,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":7.273,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":7.273,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":8,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":8,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":8,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":8.727,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":8.727,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":8.727,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":9.453,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":9.453,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":9.453,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":10.18,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":10.18,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":10.18,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":10.906,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":10.906,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":10.906,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":11.633,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":11.633,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":11.633,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":12.359,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":12.359,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":12.359,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":13.086,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":13.086,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":13.086,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":13.812,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":13.812,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":13.812,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":14.539,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":14.539,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":14.539,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":15.266,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":15.266,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":15.266,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":15.992,"w":0.375,"l":10.523,"oc":"#000000"},{"x":9.727,"y":16.719,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":15.992,"w":0.375,"l":4.563,"oc":"#000000"},{"x":20.25,"y":16.719,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":15.992,"w":0.375,"l":2.808,"oc":"#000000"},{"x":24.813,"y":16.719,"w":0.375,"l":2.808,"oc":"#000000"},{"x":9.727,"y":4.367,"w":0.375,"l":10.523,"oc":"#000000"},{"x":20.25,"y":4.367,"w":0.375,"l":4.563,"oc":"#000000"},{"x":24.813,"y":4.367,"w":0.375,"l":2.808,"oc":"#000000"}],"VLines":[{"x":9.735,"y":2.922,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":2.922,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":2.922,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":2.922,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":4.375,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":4.375,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":4.375,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":4.375,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":5.102,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":5.102,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":5.102,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":5.102,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":5.828,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":5.828,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":5.828,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":5.828,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":6.555,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":6.555,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":7.281,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":7.281,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":7.281,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":7.281,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":8.008,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":8.008,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":8.008,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":8.008,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":8.734,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":8.734,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":8.734,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":8.734,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":9.461,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":9.461,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":9.461,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":9.461,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":10.187,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":10.187,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":10.187,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":10.187,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":10.914,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":10.914,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":10.914,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":10.914,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":11.641,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":11.641,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":12.367,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":12.367,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":12.367,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":12.367,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":13.094,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":13.094,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":13.094,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":13.094,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":13.82,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":13.82,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":13.82,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":13.82,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":14.547,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":14.547,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":14.547,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":14.547,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":15.273,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":15.273,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":15.273,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":15.273,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":16,"w":0.375,"l":0.711,"oc":"#000000"},{"x":20.25,"y":16,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.813,"y":16,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":16,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":3.648,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.612,"y":3.648,"w":0.375,"l":0.711,"oc":"#000000"}],"Fills":[{"x":23.91,"y":0.537,"w":10.734,"h":1.113,"oc":"#838f97"},{"x":0,"y":-0.531,"w":37.736,"h":1.152,"oc":"#838f97"},{"x":0,"y":-0.531,"w":37.736,"h":2.339,"oc":"#838f97"},{"x":9.735,"y":2.914,"w":17.877,"h":0.727,"oc":"#a7a9ac"}],"Texts":[{"x":2.29,"y":0.6539999999999999,"w":15.863,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports%2F","S":-1,"TS":[0,13,0,0]}]},{"x":24.108,"y":0.6419999999999999,"w":15.543,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports","S":-1,"TS":[0,13.25,0,0]}]},{"x":20.188,"y":2.641,"w":9.931,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Correlation%20coefficientP","S":8,"TS":[0,10,1,0]}]},{"x":25.042,"y":2.641,"w":2.088,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"%20Value","S":8,"TS":[0,10,1,0]}]},{"x":9.673,"y":3.367,"w":8.168,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"General%20parameters","S":8,"TS":[0,10,1,0]}]},{"x":9.673,"y":4.094,"w":1.545,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Age","S":2,"TS":[0,10,0,0]}]},{"x":20.528,"y":4.094,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.18","S":2,"TS":[0,10,0,0]}]},{"x":24.751,"y":4.094,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.14","S":2,"TS":[0,10,0,0]}]},{"x":9.673,"y":4.821,"w":1.371,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Sex","S":2,"TS":[0,10,0,0]}]},{"x":20.529,"y":4.821,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.018","S":2,"TS":[0,10,0,0]}]},{"x":24.751,"y":4.821,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.88","S":2,"TS":[0,10,0,0]}]},{"x":9.674,"y":5.547,"w":15.741,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20reticular%20pseudodrusen0.23","S":2,"TS":[0,10,0,0]}]},{"x":24.751,"y":5.547,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.055","S":2,"TS":[0,10,0,0]}]},{"x":9.674,"y":6.274,"w":10.998,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Clinical%20factors%20at%20baseline","S":8,"TS":[0,10,1,0]}]},{"x":9.674,"y":7.001,"w":14.289,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Central%20retinal%20thickness%20(CRT)0.10","S":2,"TS":[0,10,0,0]}]},{"x":24.752,"y":7.001,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.400","S":2,"TS":[0,10,0,0]}]},{"x":9.675,"y":7.727,"w":24.811,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Maximum%20height%20of%20the%20pigment%20epithelium%20detachment0.023","S":2,"TS":[0,10,0,0]}]},{"x":24.752,"y":7.727,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.850","S":2,"TS":[0,10,0,0]}]},{"x":9.675,"y":8.454,"w":8.037,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Choroidal%20thickness","S":2,"TS":[0,10,0,0]}]},{"x":20.19,"y":8.454,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":20.53,"y":8.454,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.24","S":2,"TS":[0,10,0,0]}]},{"x":24.753,"y":8.454,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.038","S":2,"TS":[0,10,0,0]}]},{"x":26.139,"y":9.031,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.361,"y":9.031,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"5","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.676,"y":9.181,"w":5.977,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20EZ","S":2,"TS":[0,10,0,0]}]},{"x":20.191,"y":9.181,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":20.531,"y":9.181,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.49","S":2,"TS":[0,10,0,0]}]},{"x":24.753,"y":9.181,"w":1.415,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"1.1%20","S":2,"TS":[0,10,0,0]}]},{"x":25.328,"y":9.181,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.623,"y":9.181,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":26.139,"y":9.757,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.361,"y":9.757,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"4","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.673,"y":9.906,"w":6.803,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20ELM","S":2,"TS":[0,10,0,0]}]},{"x":20.188,"y":9.906,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":20.528,"y":9.906,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.41","S":2,"TS":[0,10,0,0]}]},{"x":24.75,"y":9.906,"w":1.415,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2.7%20","S":2,"TS":[0,10,0,0]}]},{"x":25.325,"y":9.906,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.62,"y":9.906,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":9.673,"y":10.633,"w":13.559,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20vitreous%20adhesion0.19","S":2,"TS":[0,10,0,0]}]},{"x":24.75,"y":10.633,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.110","S":2,"TS":[0,10,0,0]}]},{"x":9.673,"y":11.359,"w":11.119,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Clinical%20factors%20at%20year%20one","S":8,"TS":[0,10,1,0]}]},{"x":9.673,"y":12.086,"w":12.621,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Central%20retinal%20thickness%20(CRT)","S":2,"TS":[0,10,0,0]}]},{"x":20.188,"y":12.086,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":20.528,"y":12.086,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.28","S":2,"TS":[0,10,0,0]}]},{"x":24.751,"y":12.086,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.018","S":2,"TS":[0,10,0,0]}]},{"x":9.674,"y":12.813,"w":24.331,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Maximum%20height%20of%20the%20pigment%20epithelium%20detachment0.23","S":2,"TS":[0,10,0,0]}]},{"x":24.751,"y":12.813,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.053","S":2,"TS":[0,10,0,0]}]},{"x":9.674,"y":13.54,"w":8.037,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Choroidal%20thickness","S":2,"TS":[0,10,0,0]}]},{"x":20.189,"y":13.54,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":20.529,"y":13.54,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.25","S":2,"TS":[0,10,0,0]}]},{"x":24.752,"y":13.54,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.033","S":2,"TS":[0,10,0,0]}]},{"x":26.139,"y":14.117,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.361,"y":14.117,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"6","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.674,"y":14.266,"w":5.977,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20EZ","S":2,"TS":[0,10,0,0]}]},{"x":20.189,"y":14.266,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":20.53,"y":14.266,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.50","S":2,"TS":[0,10,0,0]}]},{"x":24.752,"y":14.266,"w":1.415,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"6.8%20","S":2,"TS":[0,10,0,0]}]},{"x":25.326,"y":14.266,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.622,"y":14.266,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":26.139,"y":14.843,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.361,"y":14.843,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"5","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.673,"y":14.992,"w":6.803,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20ELM","S":2,"TS":[0,10,0,0]}]},{"x":20.188,"y":14.992,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":20.528,"y":14.992,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.47","S":2,"TS":[0,10,0,0]}]},{"x":24.75,"y":14.992,"w":1.415,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2.7%20","S":2,"TS":[0,10,0,0]}]},{"x":25.325,"y":14.992,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.62,"y":14.992,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":9.673,"y":15.719000000000001,"w":13.559,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20vitreous%20adhesion0.27","S":2,"TS":[0,10,0,0]}]},{"x":24.75,"y":15.719000000000001,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.023","S":2,"TS":[0,10,0,0]}]},{"x":9.477,"y":16.977,"w":3.327,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Table%201.","S":9,"TS":[0,12,1,0]}]},{"x":11.324,"y":16.977,"w":38.949999999999996,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Correlation%20between%20clinical%20characteristics%20and%20four-year%20visual%20outcome%20in%20age-related%20macular%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":17.601,"w":18.385,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"degeneration%20patients%20treated%20with%20aflibercept.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":20.039,"w":45.154,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"thickness%2C%20and%20the%20maximum%20height%20of%20the%20pigment%20epithelium%20detachment.%20The%20measurement%20of%20CRT%20and%20subfo-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":20.664,"w":45.035,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"veal%20choroidal%20thickness%20was%20done%20in%20horizontal%20and%20vertical%20scans%2C%20and%20the%20mean%20value%20was%20used%20for%20the%20analysis.%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":21.289,"w":44.774,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"The%20presence%20of%20external%20limiting%20membrane%20(ELM)%2Fellipsoid%20zone%20(EZ)%2C%20vitreoretinal%20adhesions%2C%20and%20reticular%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":21.914,"w":44.902,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"pseudodrusen%20was%20also%20graded%20by%20two%20of%20the%20authors%20(KN%20and%20AO).%20Any%20discrepancy%20in%20grading%20was%20arbitrated%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":22.539,"w":7.089,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"with%20a%20discussion.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":23.164,"w":43.801,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"We%20investigated%20changes%20in%20visual%20acuity%20as%20a%20main%20outcome%20measure.%20Changes%20in%20visual%20acuity%20in%20subgroups%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":23.789,"w":44.910000000000004,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"(who%20had%20better%20baseline%20visual%20acuity%20or%20fewer%20number%20of%20injections)%20were%20also%20investigated.%20In%20addition%2C%20we%20per-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":24.414,"w":41.924,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"formed%20multivariate%20regression%20analysis%20to%20identify%20the%20baseline%20characteristics%20predicting%20visual%20outcome.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":25.541,"w":8.621,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Statistical%20analysis.%20","S":-1,"TS":[2,14,1,0]}]},{"x":15.356,"y":25.541,"w":34.319,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"The%20data%20are%20shown%20as%20mean%20and%2095%25%20confidence%20interval%20unless%20otherwise%20specified.%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":26.166,"w":45.295,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Statistical%20analysis%20was%20carried%20out%20using%20SPSS%20version%2019%20(IBM%20Japan%2C%20Tokyo%2C%20Japan).%20A%20P-value%20smaller%20than%200.05%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":26.791,"w":44.841,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"was%20considered%20significant.%20Visual%20acuity%20was%20measured%20with%20Landolt%20C%20charts%20and%20was%20converted%20to%20logarithm%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":27.416,"w":44.53,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"of%20minimum%20angle%20of%20resolution%20(logMAR)%20for%20the%20analysis.%20While%20we%20used%20the%20results%20of%20survivors%20(who%20com-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":28.041,"w":44.913000000000004,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"pleted%20four-year%20follow%20up)%2C%20data%20that%20included%20the%20dropout%20patients%20were%20also%20analyzed%20using%20a%20last%20observation%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":28.666,"w":44.803,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"carried%20forward%20policy%20for%20sensitivity%20analysis.%20To%20compare%20changes%20from%20baseline%2C%20repeated%20measures%20ANOVA%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":29.291,"w":44.946,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"with%20post%20hoc%20Dunnet%20correction%20was%20applied.%20Shapiro-Wilk%20test%20showed%20that%20age%20followed%20normal%20distribution%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":29.916,"w":45.284,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"and%20the%20other%20investigated%20factors%20followed%20non-normal%20distribution.%20Bivariate%20relationships%20were%20examined%20using%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":30.541,"w":45.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Pearson%E2%80%99s%20correlation%20coefficient%20for%20age%20and%20using%20Spearman%E2%80%99s%20correlation%20coefficient%20test%20for%20the%20other%20continuous%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":31.166,"w":45.402,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"variables%20and%20binary%20variables.%20Step-wise%20multivariate%20regression%20analysis%20was%20performed%20with%20age%2C%20CRT%2C%20choroidal%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":31.79,"w":44.916,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"thickness%2C%20presence%20or%20absence%20of%20ELM%2C%20EZ%2C%20and%20vitreoretinal%20adhesion%20as%20independent%20factors%20and%20visual%20acuity%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":32.415,"w":13.579,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"at%20year%20four%20as%20a%20dependent%20factor.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":33.543,"w":3.165,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Results","S":-1,"TS":[0,15,1,0]}]},{"x":9.477,"y":34.168,"w":45.28,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Among%20the%2098%20eyes%20of%2098%20patients%2C%2025%20(25.5%25)%20dropped%20out%20during%20the%20follow-up%20period.%20Baseline%20characteristics%20of%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":34.793,"w":44.95,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"survivors%20and%20dropouts%20are%20shown%20in%20Supplementary%20Table.%20In%20summary%2C%20dropout%20patients%20had%20worse%20visual%20acu-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":35.418,"w":44.991,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"ity%20and%C2%A0tended%20to%20be%20male.%20Reasons%20for%20dropout%20included%20death%20(unknown%20reason%2C%20one%20patient)%2C%20illness%20(cerebral%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":36.043,"w":44.959,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"infarction%2C%20one%20patient%3B%20non-Hodgkin%20lymphoma%3B%20one%20patient%2C%20traffic%20accident%2C%20one%20patient)%2C%20and%20socioeconomic%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":36.668,"w":34.28,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"reasons%20(6%20patients).%20Fifteen%20patients%20did%20not%20return%20the%20hospital%20for%20unknown%20reasons.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":37.293,"w":43.415,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"The%20study%20sample%20comprised%2032%20patients%20with%20typical%20AMD%2C%2033%20patients%20with%20polypoidal%20choroidal%20vasculopa-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":37.918,"w":45.585,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"thy%2C%20and%208%20patients%20with%20retinal%20angiomatous%20proliferation.%20The%20patients%20received%207.0%20(6.9%20to%207.1)%2C%202.5%20(1.9%20to%203.1)%2C%202.7%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":38.543,"w":37.339,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"(2.1%20to%203.4)%2C%20and%202.7%20(2.2%20to%203.3)%20injections%20at%20year%20one%2C%20two%2C%20three%2C%20and%20four%2C%20respectively%20(Fig.%C2%A01","S":3,"TS":[0,12,0,0]}]},{"x":30.155,"y":38.543,"w":7.914,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%3B%20top).%20Five%20patients%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":39.168,"w":44.77,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"also%20underwent%20photodynamic%20therapy%20combined%20with%20aflibercept.%20A%20histogram%20of%20the%20number%20of%20injections%20is%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":39.793,"w":6.112,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"shown%20in%20Fig.%C2%A01","S":3,"TS":[0,12,0,0]}]},{"x":12.833,"y":39.793,"w":39.182,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20(bottom).%20The%20result%20shows%20bimodal%20distribution%3B%20some%20patients%20required%20no%20additional%20treatment%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":40.417,"w":23.6,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"after%20one%20year%2C%20while%20others%20required%20continuous%20injections.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":41.042,"w":34.459999999999994,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Visual%20outcome%20of%20patients%20who%20completed%20the%20four-year%20follow-up%20is%20shown%20in%20Fig.%C2%A02","S":3,"TS":[0,12,0,0]}]},{"x":29.372,"y":41.042,"w":9.312,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20(top).%20Visual%20gain%20was%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":41.667,"w":12.725999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.14%20at%20year%20one%20(0.01%20to%200.28%2C%20P%20","S":3,"TS":[0,12,0,0]}]},{"x":16.504,"y":41.667,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":16.936,"y":41.667,"w":10.063,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%200.033)%2C%200.13%20at%20year%20two%20(","S":3,"TS":[0,12,0,0]}]},{"x":22.514,"y":41.667,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":44,"TS":[2,12,0,0]}]},{"x":22.932,"y":41.667,"w":5.866,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.01%20to%200.27%2C%20P%20","S":3,"TS":[0,12,0,0]}]},{"x":26.152,"y":41.667,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":26.584,"y":41.667,"w":10.625,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%200.069)%2C%200.07%20at%20year%20three%20(","S":3,"TS":[0,12,0,0]}]},{"x":32.478,"y":41.667,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":44,"TS":[2,12,0,0]}]},{"x":32.897,"y":41.667,"w":2.945,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.06%20to%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":42.292,"w":2.8970000000000002,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.21%2C%20P%20","S":3,"TS":[0,12,0,0]}]},{"x":11.032,"y":42.292,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":11.449,"y":42.292,"w":11.921,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%200.557)%2C%20and%200.06%20at%20year%20four%20(","S":3,"TS":[0,12,0,0]}]},{"x":18.002,"y":42.292,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":44,"TS":[2,12,0,0]}]},{"x":18.406,"y":42.292,"w":5.818,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.07%20to%200.20%2C%20P%20","S":3,"TS":[0,12,0,0]}]},{"x":21.562,"y":42.292,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":21.98,"y":42.292,"w":22.539,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%200.697).%20For%20comparison%2C%20visual%20outcome%20of%20all%20patients%E2%80%94","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":42.917,"w":28.064,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"including%20those%20who%20dropped%20out%E2%80%94is%20shown%20with%20a%20dotted%20line%20(Fig.%C2%A02","S":3,"TS":[0,12,0,0]}]},{"x":25.109,"y":42.917,"w":16.889,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20top).%20Survivors%20had%20better%20baseline%20visual%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":43.542,"w":45.238,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"acuity%2C%20but%20the%20gain%20of%20vision%20and%20subsequent%20loss%20of%20vision%20thereafter%20was%20similar%20with%20the%20dropout-imputed%20data.%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":44.167,"w":35.348,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"The%20prevalence%20of%20patients%20who%20gained%20or%20lost%20more%20than%200.3%20logMAR%20is%20shown%20in%20Fig.%C2%A02","S":3,"TS":[0,12,0,0]}]},{"x":29.23,"y":44.167,"w":9.58,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20(bottom).%20At%20year%20one%2C%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":44.792,"w":44.597,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"all%20the%20patients%20had%20gained%20or%20maintained%20vision.%20In%20the%20following%20years%2C%20some%20patients%20lost%20vision%2C%20but%2094.5%25%20","S":3,"TS":[0,12,0,0]}]},{"x":2.3,"y":47.015,"w":5.514,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"Scientific%20","S":-1,"TS":[0,11,0,0]}]},{"x":5.048,"y":47.015,"w":3.429,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"RepoR","S":-1,"TS":[0,11,1,0]}]},{"x":6.762,"y":47.015,"w":1.255,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"ts","S":-1,"TS":[0,11,1,0]}]},{"x":7.37,"y":47.015,"w":7.835999999999999,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20%20%20%20%20%20%20%20%20%20(2019)%209%3A3620%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.268,"y":47.015,"w":0.627,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.572,"y":47.015,"w":18.416,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"https%3A%2F%2Fdoi.org%2F10.1038%2Fs41598-019-39995-5","S":-1,"TS":[2,11,0,0]}]},{"x":34.132,"y":47.014,"w":0.453,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"3","S":-1,"TS":[0,13,0,0]}]}],"Fields":[],"Boxsets":[]},{"Width":37.205,"Height":48.898,"HLines":[{"x":2.54,"y":47.034,"w":0.45,"l":32.125,"oc":"#000000"},{"x":9.946,"y":30.473,"w":1.5,"l":24.594,"oc":"#838f97","dsh":1}],"VLines":[],"Fills":[{"x":-0.531,"y":-0.531,"w":37.736,"h":1.152,"oc":"#838f97"},{"x":23.912,"y":0.54,"w":10.734,"h":1.113,"oc":"#838f97"},{"x":-0.531,"y":-0.531,"w":37.736,"h":2.339,"oc":"#838f97"}],"Texts":[{"x":2.29,"y":0.6539999999999999,"w":15.863,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports%2F","S":-1,"TS":[0,13,0,0]}]},{"x":24.108,"y":0.6419999999999999,"w":15.543,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports","S":-1,"TS":[0,13.25,0,0]}]},{"x":9.477,"y":24.098,"w":3.708,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Figure%202.","S":9,"TS":[0,12,1,0]}]},{"x":11.538,"y":24.098,"w":40.087999999999994,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Visual%20outcome%20of%20eyes%20with%20neovascular%20age-related%20macular%20degeneration%20treated%20with%20intravitreal%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":24.723,"w":44.359,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"aflibercept%20injections.%20The%20solid%20line%20in%20the%20top%20panel%20shows%20the%20overall%20result%20of%20eyes%2C%20which%20completed%20the%20four-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":25.348,"w":43.465,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"year%20follow-up.%20Visual%20gain%20in%20the%20first%20year%20was%20gradually%20lost%20in%20the%20following%20years%2C%20but%20the%20vision%20remained%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":25.972,"w":42.291,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"above%20the%20baseline%20level%20even%20at%20year%20four.%20A%20dotted%20line%20shows%20the%20data%20of%20all%20patients%20including%20those%20who%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":26.597,"w":31.67,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"dropped%20out.%20Missing%20data%20were%20imputed%20with%20a%20last%20observation%20carried%20forward","S":3,"TS":[0,12,0,0]}]},{"x":27.065,"y":26.597,"w":12.777,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20policy.%20The%20visual%20course%20in%20the%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":27.222,"w":44.949,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"cohort%20was%20essentially%20similar%20despite%20the%20difference%20of%20baseline%20visual%20acuity%2C%20indicating%20the%20data%20of%20survivors%20can%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":27.847,"w":44.009,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"be%20approximated%20as%20a%20representation%20of%20the%20overall%20cohort.%20The%20bottom%20graph%20shows%20the%20percentage%20of%20patients%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":28.472,"w":44.598,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"who%20gained%20or%20lost%20more%20than%20three%20lines%20of%20vision.%20All%20the%20patients%20gained%20or%20maintained%20vision%20in%20the%20first%20year.%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":29.097,"w":42.344,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Although%20some%20patients%20lost%20vision%20in%20the%20following%20years%2C%2094.5%25%20maintained%20their%20vision%20even%20at%20year%20four.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":31.656,"w":42.061,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"maintained%20their%20vision%20through%20year%20four.%20Gain%20of%20vision%20was%200.07%20(0.01%20to%200.14)%20in%20typical%20AMD%2C%200.08%20(","S":3,"TS":[0,12,0,0]}]},{"x":33.137,"y":31.656,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":44,"TS":[2,12,0,0]}]},{"x":33.461,"y":31.656,"w":1.94,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.01%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":32.281,"w":8.578,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"to%200.16)%20in%20PCV%2C%20and%20","S":3,"TS":[0,12,0,0]}]},{"x":14.196,"y":32.281,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":44,"TS":[2,12,0,0]}]},{"x":14.638,"y":32.281,"w":2.277,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.02%20(","S":3,"TS":[0,12,0,0]}]},{"x":15.915,"y":32.281,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":44,"TS":[2,12,0,0]}]},{"x":16.357,"y":32.281,"w":32.56,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.22%20to%200.18)%20in%20RAP%20patients%2C%20and%20there%20was%20no%20difference%20among%20the%20subgroups%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":32.906,"w":1.1360000000000001,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"(P%20","S":3,"TS":[0,12,0,0]}]},{"x":10.059,"y":32.906,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":10.439,"y":32.906,"w":2.949,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%200.513).","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":33.531,"w":18.974,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Visual%20outcome%20in%20eyes%20with%20baseline%20logMAR%20","S":3,"TS":[0,12,0,0]}]},{"x":20.782,"y":33.531,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":21.225,"y":33.531,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":21.3,"y":33.531,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3C","S":44,"TS":[2,12,0,0]}]},{"x":21.741,"y":33.531,"w":7.317,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%200.2%20(36%20eyes)%20and%20","S":3,"TS":[0,12,0,0]}]},{"x":25.794,"y":33.531,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3E","S":44,"TS":[2,12,0,0]}]},{"x":26.231,"y":33.531,"w":12.419,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.2%20(37%20eyes)%20is%20shown%20in%20Fig.%C2%A03","S":3,"TS":[0,12,0,0]}]},{"x":33.198,"y":33.531,"w":2.423,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20(top%3B%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":34.156,"w":44.338,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"cut%20off%20value%20of%200.2%20is%20based%20on%20median%200.22).%20The%20visual%20course%20was%20different%20between%20the%20cases%2C%20as%20expected%20","S":3,"TS":[0,12,0,0]}]},{"x":12.424,"y":34.59,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,8.8499999,0,0]}]},{"x":12.712,"y":34.59,"w":0.98,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"44","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":34.781,"w":1.166,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"(P%20","S":3,"TS":[0,12,0,0]}]},{"x":10.075,"y":34.781,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":10.461,"y":34.781,"w":1.455,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%201.5","S":3,"TS":[0,12,0,0]}]},{"x":11.222,"y":34.781,"w":0.237,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":11.354,"y":34.781,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":44,"TS":[2,12,0,0]}]},{"x":11.74,"y":34.781,"w":1.217,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":3,"TS":[0,12,0,0]}]},{"x":13.07,"y":34.781,"w":38.304,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":").%20While%20those%20with%20worse%20baseline%20logMAR%20gained%20greater%20vision%20in%20the%20first%20year%20(0.2%20vs%200.08%2C%20","S":3,"TS":[0,12,0,0]}]},{"x":12.213,"y":35.215,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,8.8499999,0,0]}]},{"x":12.501,"y":35.215,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"4","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.478,"y":35.406,"w":0.8059999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"P%20","S":3,"TS":[0,12,0,0]}]},{"x":9.874,"y":35.406,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":10.259,"y":35.406,"w":1.447,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%208.1","S":3,"TS":[0,12,0,0]}]},{"x":11.016,"y":35.406,"w":0.235,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":11.148,"y":35.406,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":44,"TS":[2,12,0,0]}]},{"x":11.532,"y":35.406,"w":1.2109999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":3,"TS":[0,12,0,0]}]},{"x":12.679,"y":35.406,"w":39.134,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":")%2C%20both%20groups%20showed%20similar%20changes%20in%20the%20subsequent%20three%20years.%20The%20change%20in%20vision%20from%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":36.031,"w":35.906,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"year%20one%20to%20year%20four%20was%200.09%20and%200.06%2C%20respectively%3B%20this%20difference%20was%20not%20significant%20(P%20","S":3,"TS":[0,12,0,0]}]},{"x":29.353,"y":36.031,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":29.734,"y":36.031,"w":2.949,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%200.552).","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":36.656,"w":43.752,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"We%20also%20investigated%20visual%20outcome%20in%20eyes%20that%20underwent%20less%20than%2012%20treatments%20(36%20eyes)%20and%20that%20those%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":37.281,"w":32.821,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"that%20underwent%20greater%20than%2012%20treatments%20(37%20eyes)%3B%20results%20are%20shown%20in%20Fig.%C2%A03","S":3,"TS":[0,12,0,0]}]},{"x":27.948,"y":37.281,"w":11.762,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20(bottom%3B%20cut%20off%20value%20of%2013%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":37.906,"w":44.536,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"is%20based%20on%20the%20median).%20Visual%20gain%20in%20the%20first%20year%20was%20gradually%20lost%20in%20the%20following%20years%2C%20but%20the%20vision%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":38.531,"w":45.306000000000004,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"remained%20above%20the%20baseline%20level%20even%20at%20year%20four%20in%20both%20groups.%20Two-way%20ANOVA%20showed%20difference%20in%20over-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":39.156,"w":15.746,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"all%20visual%20course%20between%20the%20groups%20(P%20","S":3,"TS":[0,12,0,0]}]},{"x":18.191,"y":39.156,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":18.616,"y":39.156,"w":23.34,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%200.004)%20despite%20no%20significant%20difference%20at%20each%20time%20point.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":39.781,"w":2.925,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Table%C2%A01","S":3,"TS":[0,12,0,0]}]},{"x":11.8,"y":39.781,"w":40.542,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20shows%20the%20result%20of%20univariate%20association%20between%20clinical%20factors%20at%20baseline%2C%20year%20one%2C%20and%20visual%20out-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":40.406,"w":44.867,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"come%20at%20year%20four.%20The%20presence%20of%20EZ%2FELM%20and%20choroidal%20thickness%20at%20baseline%20were%20associated%20with%20final%20visual%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":41.031,"w":45.041,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"outcome.%20Findings%20at%20year%20one%20showed%20a%20similar%20tendency%3B%20the%20presence%20of%20EZ%2C%20ELM%2C%20and%20vitreous%20adhesion%2C%20CRT%2C%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":41.656,"w":44.285999999999994,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"and%20choroidal%20thickness%20at%20year%20one%20showed%20a%20significant%20association.%20After%20the%20stepwise%20variable%20selection%20(Table%C2%A02","S":3,"TS":[0,12,0,0]}]},{"x":34.097,"y":41.656,"w":0.771,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":")%2C%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":42.281,"w":45.293,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"the%20presence%20of%20ELM%2C%20vitreous%20adhesion%2C%20and%20choroidal%20thickness%20were%20found%20to%20be%20significant%20among%20baseline%20factors%20","S":3,"TS":[0,12,0,0]}]},{"x":18.264,"y":42.715,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,8.8499999,0,0]}]},{"x":18.543,"y":42.715,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"6","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":26.959,"y":42.715,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,8.8499999,0,0]}]},{"x":27.237,"y":42.715,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":33.838,"y":42.715,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,8.8499999,0,0]}]},{"x":34.117,"y":42.715,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"4","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":42.905,"w":6.603,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"(Coefficient%20beta%20","S":3,"TS":[0,12,0,0]}]},{"x":13.122,"y":42.905,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":13.551,"y":42.905,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":13.613,"y":42.905,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":44,"TS":[2,12,0,0]}]},{"x":14.041,"y":42.905,"w":3.258,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.388%2C%20P%20","S":3,"TS":[0,12,0,0]}]},{"x":15.795000000000002,"y":42.905,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":16.166,"y":42.905,"w":1.82,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%207.34","S":3,"TS":[0,12,0,0]}]},{"x":17.132,"y":42.905,"w":0.212,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":17.252,"y":42.905,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":44,"TS":[2,12,0,0]}]},{"x":17.622,"y":42.905,"w":1.1420000000000001,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":3,"TS":[0,12,0,0]}]},{"x":18.713,"y":42.906,"w":6.455,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%3B%20coefficient%20beta%20","S":3,"TS":[0,12,0,0]}]},{"x":22.246,"y":42.906,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":22.617,"y":42.906,"w":3.258,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%200.201%2C%20P","S":3,"TS":[0,12,0,0]}]},{"x":24.335,"y":42.906,"w":0.212,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":24.454,"y":42.906,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":24.861,"y":42.906,"w":1.82,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%201.31","S":3,"TS":[0,12,0,0]}]},{"x":25.827,"y":42.906,"w":0.212,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":25.946,"y":42.906,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":44,"TS":[2,12,0,0]}]},{"x":26.317,"y":42.906,"w":1.1420000000000001,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":3,"TS":[0,12,0,0]}]},{"x":27.407,"y":42.906,"w":6.455,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%3B%20coefficient%20beta%20","S":3,"TS":[0,12,0,0]}]},{"x":30.94,"y":42.906,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":31.369,"y":42.906,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":31.431,"y":42.906,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":44,"TS":[2,12,0,0]}]},{"x":31.859,"y":42.906,"w":1.82,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"7.66%20","S":3,"TS":[0,12,0,0]}]},{"x":32.825,"y":42.906,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":44,"TS":[2,12,0,0]}]},{"x":33.196,"y":42.906,"w":1.1420000000000001,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":3,"TS":[0,12,0,0]}]},{"x":34.287,"y":42.906,"w":0.455,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20","S":3,"TS":[0,12,0,0]}]},{"x":12.352,"y":43.34,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,8.8499999,0,0]}]},{"x":12.633,"y":43.34,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.478,"y":43.531,"w":0.77,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"P%20","S":3,"TS":[0,12,0,0]}]},{"x":9.853,"y":43.531,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":10.228,"y":43.531,"w":1.845,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%202.77","S":3,"TS":[0,12,0,0]}]},{"x":11.208,"y":43.531,"w":0.217,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":11.329,"y":43.531,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":44,"TS":[2,12,0,0]}]},{"x":11.703,"y":43.531,"w":1.157,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":3,"TS":[0,12,0,0]}]},{"x":12.805,"y":43.531,"w":39.361,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20respectively)%2C%20while%20the%20presence%20of%20EZ%2C%20ELM%2C%20and%20vitreous%20adhesion%20at%20year%20one%20was%20associated%20with%20","S":3,"TS":[0,12,0,0]}]},{"x":22,"y":43.965,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,8.8499999,0,0]}]},{"x":22.283,"y":43.965,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":31.419,"y":43.965,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,8.8499999,0,0]}]},{"x":31.702,"y":43.965,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.478,"y":44.156,"w":12.985999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"visual%20outcome%20(Coefficient%20beta%20","S":3,"TS":[0,12,0,0]}]},{"x":16.703,"y":44.156,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":17.138,"y":44.156,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":17.206,"y":44.156,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":44,"TS":[2,12,0,0]}]},{"x":17.641,"y":44.156,"w":3.348,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.163%2C%20P%20","S":3,"TS":[0,12,0,0]}]},{"x":19.464,"y":44.156,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":19.842,"y":44.156,"w":1.8699999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%209.87","S":3,"TS":[0,12,0,0]}]},{"x":20.836,"y":44.156,"w":0.222,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":20.961,"y":44.156,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":44,"TS":[2,12,0,0]}]},{"x":21.34,"y":44.156,"w":1.172,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":3,"TS":[0,12,0,0]}]},{"x":22.457,"y":44.156,"w":6.625,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%3B%20coefficient%20beta%20","S":3,"TS":[0,12,0,0]}]},{"x":26.122,"y":44.156,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":26.558,"y":44.156,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":26.625,"y":44.156,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":44,"TS":[2,12,0,0]}]},{"x":27.061,"y":44.156,"w":3.348,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.255%2C%20P%20","S":3,"TS":[0,12,0,0]}]},{"x":28.883,"y":44.156,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":29.261,"y":44.156,"w":1.8699999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%202.79","S":3,"TS":[0,12,0,0]}]},{"x":30.256,"y":44.156,"w":0.222,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":30.38,"y":44.156,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":44,"TS":[2,12,0,0]}]},{"x":30.76,"y":44.156,"w":1.172,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":3,"TS":[0,12,0,0]}]},{"x":31.875999999999998,"y":44.156,"w":4.746,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%3B%20coefficient%20","S":3,"TS":[0,12,0,0]}]},{"x":15.258,"y":44.59,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,8.8499999,0,0]}]},{"x":15.539,"y":44.59,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":19.278,"y":44.59,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":44.781,"w":1.854,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"beta%20","S":3,"TS":[0,12,0,0]}]},{"x":10.471,"y":44.781,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":10.846,"y":44.781,"w":3.303,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%200.203%2C%20P","S":3,"TS":[0,12,0,0]}]},{"x":12.589,"y":44.781,"w":0.217,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":12.711,"y":44.781,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":13.13,"y":44.781,"w":1.845,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%201.85","S":3,"TS":[0,12,0,0]}]},{"x":14.111,"y":44.781,"w":0.217,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":14.233,"y":44.781,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":44,"TS":[2,12,0,0]}]},{"x":14.607,"y":44.781,"w":1.157,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":3,"TS":[0,12,0,0]}]},{"x":15.711,"y":44.781,"w":24.811,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20respectively).%20R%20of%20the%20model%20was%200.351%20and%200.350%2C%20respectively.","S":3,"TS":[0,12,0,0]}]},{"x":2.3,"y":47.015,"w":5.514,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"Scientific%20","S":-1,"TS":[0,11,0,0]}]},{"x":5.048,"y":47.015,"w":3.429,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"RepoR","S":-1,"TS":[0,11,1,0]}]},{"x":6.762,"y":47.015,"w":1.255,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"ts","S":-1,"TS":[0,11,1,0]}]},{"x":7.37,"y":47.015,"w":7.835999999999999,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20%20%20%20%20%20%20%20%20%20(2019)%209%3A3620%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.268,"y":47.015,"w":0.627,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.572,"y":47.015,"w":18.416,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"https%3A%2F%2Fdoi.org%2F10.1038%2Fs41598-019-39995-5","S":-1,"TS":[2,11,0,0]}]},{"x":34.092,"y":47.014,"w":0.517,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"4","S":-1,"TS":[0,13,0,0]}]}],"Fields":[],"Boxsets":[]},{"Width":37.205,"Height":48.898,"HLines":[{"x":2.54,"y":47.034,"w":0.45,"l":32.125,"oc":"#000000"},{"x":9.946,"y":29.818,"w":1.5,"l":24.594,"oc":"#838f97","dsh":1}],"VLines":[],"Fills":[{"x":23.91,"y":0.537,"w":10.734,"h":1.113,"oc":"#838f97"},{"x":0,"y":-0.531,"w":37.736,"h":1.152,"oc":"#838f97"},{"x":0,"y":-0.531,"w":37.736,"h":2.339,"oc":"#838f97"}],"Texts":[{"x":2.29,"y":0.6539999999999999,"w":15.863,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports%2F","S":-1,"TS":[0,13,0,0]}]},{"x":24.108,"y":0.6419999999999999,"w":15.543,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports","S":-1,"TS":[0,13.25,0,0]}]},{"x":9.477,"y":24.068,"w":3.708,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Figure%203.","S":9,"TS":[0,12,1,0]}]},{"x":11.538,"y":24.068,"w":40.087999999999994,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Visual%20outcome%20of%20eyes%20with%20neovascular%20age-related%20macular%20degeneration%20treated%20with%20intravitreal%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":24.693,"w":44.632,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"aflibercept%20injections.%20The%20top%20graph%20shows%20visual%20outcome%20in%20eyes%20with%20a%20baseline%20logarithm%20of%20minimum%20angle%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":25.318,"w":44.223,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"of%20resolution%20(logMAR)%20better%20than%200.2%2C%20or%20not.%20Those%20with%20poor%20visual%20acuity%20at%20baseline%20gained%20more%20vision%20in%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":25.942,"w":44.414,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"the%20first%20year.%20However%2C%20both%20groups%20showed%20similar%20decline%20of%20vision%20in%20the%20following%20year.%20The%20visual%20outcome%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":26.567,"w":42.448,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"of%20the%20group%20with%20poor%20baseline%20vision%20did%20not%20reach%20the%20same%20level%20of%20visual%20acuity%20as%20the%20group%20with%20good%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":27.192,"w":43.814,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"baseline%20vision.%20The%20bottom%20graph%20shows%20visual%20outcome%20in%20eyes%20that%20received%20more%20or%20less%20than%2012%20injections.%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":27.817,"w":43.041,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Interestingly%20in%20this%20cohort%2C%20fewer%20number%20of%20injections%20was%20not%20associated%20with%20limited%20visual%20gain.%20Instead%2C%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":28.442,"w":33.991,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"those%20who%20received%20a%20greater%20number%20of%20injections%20showed%20slightly%20inferior%20outcomes.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":31,"w":4.554,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Discussion","S":-1,"TS":[2,15,1,0]}]},{"x":9.477,"y":31.625,"w":45.205,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"The%20results%20of%20the%20present%20study%20showed%20that%20the%20patients%20with%20neovascular%20AMD%2C%20who%20underwent%20treatment%20with%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":32.25,"w":44.862,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"aflibercept%2C%20maintained%20vision%20for%20four%20years.%20Although%20the%20maximum%20visual%20gain%20at%20year%20one%20was%20not%20retained%2C%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":32.875,"w":44.954,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"94.5%25%20of%20patients%20maintained%20their%20vision%2C%20which%20would%20be%20an%20acceptable%20result%20in%20clinical%20practice.%20Additionally%2C%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":33.5,"w":45.58,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"we%20found%20that%20the%20presence%20of%20ELM%20and%20vitreous%20adhesion%2C%20at%20baseline%20or%20at%20year%20one%2C%20can%20be%20a%20predictive%20factor%20for%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":34.125,"w":7.478,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"vision%20at%20year%20four.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":34.75,"w":43.475,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"The%20four-year%20visual%20outcome%20in%20our%20study%20was%20comparable%20to%20that%20of%20the%20HORIZON%20study%20and%20the%20CATT%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":35.375,"w":45.426,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"follow-up%20study.%20The%20HORIZON%20study%20showed%20that%20visual%20gain%20decreased%20to%20two%20letters%2C%20and%20maintenance%20of%20vision%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":36,"w":44.998,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"was%20achieved%20in%2080.4%25%20of%20patients%20at%20year%20four.%20The%20CATT%20follow-up%20study%20reported%20a%20loss%20of%20three%20letters%20and%20a%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":36.624,"w":45.095,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"vision%20maintenance%20rate%20of%2087.1%25%20in%205.5%20years.%20The%20results%20of%20the%20present%20study%20showed%20a%20four-year%20visual%20gain%20of%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":37.249,"w":45.389,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"logMAR%200.06%2C%20which%20corresponds%20to%20approximately%20three%20letters.%20The%20present%20results%20confirmed%20that%20visual%20gain%20in%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":37.874,"w":33.079,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"the%20first%20year%20is%20gradually%20lost%20in%20the%20following%20period%20in%20real-world%20clinical%20practice.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":38.499,"w":43.092,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"While%20the%20visual%20outcome%20was%20similar%20to%20that%20of%20previous%20studies%2C%20the%20total%20number%20of%20injections%20adminis-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":39.124,"w":44.932,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"tered%20in%20the%20present%20study%20was%20considerably%20small.%20The%20HORIZON%20study%20applied%20monthly%20injections%20during%20the%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":39.749,"w":44.984,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"first%20two%20years%20and%20then%20administered%20them%20PRN%20in%20the%20following%20two%20years.%20The%20CATT%20study%20cohort%20examined%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":40.374,"w":45.507,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"groups%20which%20had%20received%20injections%20monthly%2C%20PRN%2C%20or%20with%20a%20switch%20from%20monthly%20to%20PRN%2C%20in%20the%20first%20two%20years.%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":40.999,"w":44.612,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Meanwhile%2C%20our%20study%20used%20seven%20injections%20in%20the%20first%20year%20and%20PRN%20in%20the%20following%20three%20years.%20The%20mean%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":41.624,"w":33.324999999999996,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"number%20of%20injections%20in%20the%20four%20years%20was%2027.8%20in%20the%20HORIZON%20study%2C%2022.6%20(13.3%20","S":3,"TS":[0,12,0,0]}]},{"x":27.949,"y":41.624,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%2B","S":44,"TS":[2,12,0,0]}]},{"x":28.381,"y":41.624,"w":11.139000000000001,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%209.3)%20in%20the%20PRN%20arm%20of%20the%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":42.249,"w":45.161,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"CATT%20trial%2C%20and%2015.0%20in%20our%20study.%20We%20speculated%20that%20a%20longer%20half-life%20of%20aflibercept%20would%20partly%20contribute%20to%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":42.874,"w":44.872,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"the%20favorable%20long-term%20result.%20Considering%20that%20it%20is%20not%20easy%20to%20perform%20continuous%20anti-VEGF%20injections%20in%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":43.499,"w":32.289,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"actual%20clinical%20practice%2C%20fewer%20additional%20injections%2C%20would%20be%20beneficial%20and%20ideal.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":44.124,"w":43.31,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"The%20visual%20outcome%20was%20largely%20determined%20by%20the%20baseline%20vision.%20Those%20with%20worse%20baseline%20VA%20gained%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":44.749,"w":45.368,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"greater%20vision%20in%20the%20first%20year%20but%20the%20course%20in%20the%20subsequent%20three%20years%20were%20similar%20to%20that%20of%20those%20with%20good%20","S":3,"TS":[0,12,0,0]}]},{"x":2.3,"y":47.015,"w":5.514,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"Scientific%20","S":-1,"TS":[0,11,0,0]}]},{"x":5.048,"y":47.015,"w":3.429,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"RepoR","S":-1,"TS":[0,11,1,0]}]},{"x":6.762,"y":47.015,"w":1.255,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"ts","S":-1,"TS":[0,11,1,0]}]},{"x":7.37,"y":47.015,"w":7.835999999999999,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20%20%20%20%20%20%20%20%20%20(2019)%209%3A3620%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.268,"y":47.015,"w":0.627,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.572,"y":47.015,"w":18.416,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"https%3A%2F%2Fdoi.org%2F10.1038%2Fs41598-019-39995-5","S":-1,"TS":[2,11,0,0]}]},{"x":34.115,"y":47.014,"w":0.48,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"5","S":-1,"TS":[0,13,0,0]}]}],"Fields":[],"Boxsets":[]},{"Width":37.205,"Height":48.898,"HLines":[{"x":2.54,"y":47.034,"w":0.45,"l":32.125,"oc":"#000000"},{"x":9.946,"y":13.195,"w":1.5,"l":24.594,"oc":"#838f97","dsh":1},{"x":9.727,"y":2.914,"w":0.375,"l":5.665,"oc":"#000000"},{"x":9.727,"y":3.641,"w":0.375,"l":5.665,"oc":"#000000"},{"x":15.392,"y":2.914,"w":0.375,"l":3.358,"oc":"#000000"},{"x":15.392,"y":3.641,"w":0.375,"l":3.358,"oc":"#000000"},{"x":18.75,"y":2.914,"w":0.375,"l":5.723,"oc":"#000000"},{"x":18.75,"y":3.641,"w":0.375,"l":5.723,"oc":"#000000"},{"x":24.473,"y":2.914,"w":0.375,"l":2.557,"oc":"#000000"},{"x":24.473,"y":3.641,"w":0.375,"l":2.557,"oc":"#000000"},{"x":9.727,"y":5.094,"w":0.375,"l":5.665,"oc":"#000000"},{"x":15.392,"y":5.094,"w":0.375,"l":3.358,"oc":"#000000"},{"x":18.75,"y":5.094,"w":0.375,"l":5.723,"oc":"#000000"},{"x":24.473,"y":5.094,"w":0.375,"l":2.557,"oc":"#000000"},{"x":9.727,"y":5.82,"w":0.375,"l":5.665,"oc":"#000000"},{"x":15.392,"y":5.82,"w":0.375,"l":3.358,"oc":"#000000"},{"x":18.75,"y":5.82,"w":0.375,"l":5.723,"oc":"#000000"},{"x":24.473,"y":5.82,"w":0.375,"l":2.557,"oc":"#000000"},{"x":9.727,"y":6.547,"w":0.375,"l":5.665,"oc":"#000000"},{"x":15.392,"y":6.547,"w":0.375,"l":3.358,"oc":"#000000"},{"x":18.75,"y":6.547,"w":0.375,"l":5.723,"oc":"#000000"},{"x":24.473,"y":6.547,"w":0.375,"l":2.557,"oc":"#000000"},{"x":9.727,"y":8.727,"w":0.375,"l":5.665,"oc":"#000000"},{"x":15.392,"y":8.727,"w":0.375,"l":3.358,"oc":"#000000"},{"x":18.75,"y":8.727,"w":0.375,"l":5.723,"oc":"#000000"},{"x":24.473,"y":8.727,"w":0.375,"l":2.557,"oc":"#000000"},{"x":9.727,"y":9.453,"w":0.375,"l":5.665,"oc":"#000000"},{"x":15.392,"y":9.453,"w":0.375,"l":3.358,"oc":"#000000"},{"x":18.75,"y":9.453,"w":0.375,"l":5.723,"oc":"#000000"},{"x":24.473,"y":9.453,"w":0.375,"l":2.557,"oc":"#000000"},{"x":9.727,"y":10.18,"w":0.375,"l":5.665,"oc":"#000000"},{"x":9.727,"y":10.906,"w":0.375,"l":5.665,"oc":"#000000"},{"x":15.392,"y":10.18,"w":0.375,"l":3.358,"oc":"#000000"},{"x":15.392,"y":10.906,"w":0.375,"l":3.358,"oc":"#000000"},{"x":18.75,"y":10.18,"w":0.375,"l":5.723,"oc":"#000000"},{"x":18.75,"y":10.906,"w":0.375,"l":5.723,"oc":"#000000"},{"x":24.473,"y":10.18,"w":0.375,"l":2.557,"oc":"#000000"},{"x":24.473,"y":10.906,"w":0.375,"l":2.557,"oc":"#000000"},{"x":9.727,"y":7.273,"w":0.375,"l":5.665,"oc":"#000000"},{"x":15.392,"y":7.273,"w":0.375,"l":3.358,"oc":"#000000"},{"x":18.75,"y":7.273,"w":0.375,"l":5.723,"oc":"#000000"},{"x":24.473,"y":7.273,"w":0.375,"l":2.557,"oc":"#000000"},{"x":9.727,"y":8,"w":0.375,"l":5.665,"oc":"#000000"},{"x":15.392,"y":8,"w":0.375,"l":3.358,"oc":"#000000"},{"x":18.75,"y":8,"w":0.375,"l":5.723,"oc":"#000000"},{"x":24.473,"y":8,"w":0.375,"l":2.557,"oc":"#000000"},{"x":9.727,"y":4.367,"w":0.375,"l":5.665,"oc":"#000000"},{"x":15.392,"y":4.367,"w":0.375,"l":3.358,"oc":"#000000"},{"x":18.75,"y":4.367,"w":0.375,"l":5.723,"oc":"#000000"},{"x":24.473,"y":4.367,"w":0.375,"l":2.557,"oc":"#000000"}],"VLines":[{"x":9.735,"y":2.922,"w":0.375,"l":0.711,"oc":"#000000"},{"x":15.392,"y":2.922,"w":0.375,"l":0.711,"oc":"#000000"},{"x":18.75,"y":2.922,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.473,"y":2.922,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.023,"y":2.922,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":4.375,"w":0.375,"l":0.711,"oc":"#000000"},{"x":15.392,"y":4.375,"w":0.375,"l":0.711,"oc":"#000000"},{"x":18.75,"y":4.375,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.473,"y":4.375,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.023,"y":4.375,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":5.102,"w":0.375,"l":0.711,"oc":"#000000"},{"x":15.392,"y":5.102,"w":0.375,"l":0.711,"oc":"#000000"},{"x":18.75,"y":5.102,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.473,"y":5.102,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.023,"y":5.102,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":5.828,"w":0.375,"l":0.711,"oc":"#000000"},{"x":15.392,"y":5.828,"w":0.375,"l":0.711,"oc":"#000000"},{"x":18.75,"y":5.828,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.473,"y":5.828,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.023,"y":5.828,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":6.555,"w":0.375,"l":0.711,"oc":"#000000"},{"x":15.392,"y":6.555,"w":0.375,"l":0.711,"oc":"#000000"},{"x":18.75,"y":6.555,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.473,"y":6.555,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.023,"y":6.555,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":8.008,"w":0.375,"l":0.711,"oc":"#000000"},{"x":15.392,"y":8.008,"w":0.375,"l":0.711,"oc":"#000000"},{"x":18.75,"y":8.008,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.473,"y":8.008,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.023,"y":8.008,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":8.734,"w":0.375,"l":0.711,"oc":"#000000"},{"x":15.392,"y":8.734,"w":0.375,"l":0.711,"oc":"#000000"},{"x":18.75,"y":8.734,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.473,"y":8.734,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.023,"y":8.734,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":9.461,"w":0.375,"l":0.711,"oc":"#000000"},{"x":15.392,"y":9.461,"w":0.375,"l":0.711,"oc":"#000000"},{"x":18.75,"y":9.461,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.473,"y":9.461,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.023,"y":9.461,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":10.187,"w":0.375,"l":0.711,"oc":"#000000"},{"x":15.392,"y":10.187,"w":0.375,"l":0.711,"oc":"#000000"},{"x":18.75,"y":10.187,"w":0.375,"l":0.711,"oc":"#000000"},{"x":24.473,"y":10.187,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.023,"y":10.187,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":7.281,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.023,"y":7.281,"w":0.375,"l":0.711,"oc":"#000000"},{"x":9.735,"y":3.648,"w":0.375,"l":0.711,"oc":"#000000"},{"x":27.023,"y":3.648,"w":0.375,"l":0.711,"oc":"#000000"}],"Fills":[{"x":-0.531,"y":-0.531,"w":37.736,"h":1.152,"oc":"#838f97"},{"x":23.912,"y":0.54,"w":10.734,"h":1.113,"oc":"#838f97"},{"x":-0.531,"y":-0.531,"w":37.736,"h":2.339,"oc":"#838f97"},{"x":9.735,"y":2.914,"w":17.287,"h":0.727,"oc":"#a7a9ac"}],"Texts":[{"x":2.29,"y":0.6539999999999999,"w":15.863,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports%2F","S":-1,"TS":[0,13,0,0]}]},{"x":24.108,"y":0.6419999999999999,"w":15.543,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports","S":-1,"TS":[0,13.25,0,0]}]},{"x":15.33,"y":2.641,"w":9.478,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Coefficient%20Beta95%25CI","S":8,"TS":[0,10,1,0]}]},{"x":24.411,"y":2.641,"w":2.682,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"P%20Value","S":8,"TS":[0,10,1,0]}]},{"x":9.673,"y":3.367,"w":10.998,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Clinical%20factors%20at%20baseline","S":8,"TS":[0,10,1,0]}]},{"x":26.01,"y":3.9450000000000003,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.232,"y":3.9450000000000003,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"8","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.673,"y":4.094,"w":4.377,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"(Constant)","S":2,"TS":[0,10,0,0]}]},{"x":15.67,"y":4.094,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.648","S":2,"TS":[0,10,0,0]}]},{"x":18.688,"y":4.094,"w":4.605,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.45%20to%200.85","S":2,"TS":[0,10,0,0]}]},{"x":24.411,"y":4.094,"w":1.895,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"3.01%20","S":2,"TS":[0,10,0,0]}]},{"x":25.195,"y":4.094,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.491,"y":4.094,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":26.01,"y":4.672,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.232,"y":4.672,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"6","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.673,"y":4.82,"w":6.803,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20ELM","S":2,"TS":[0,10,0,0]}]},{"x":15.33,"y":4.82,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":15.67,"y":4.82,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.388","S":2,"TS":[0,10,0,0]}]},{"x":18.687,"y":4.82,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":19.028,"y":4.82,"w":2.937,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.54%20to%20","S":2,"TS":[0,10,0,0]}]},{"x":20.293,"y":4.82,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":20.633,"y":4.82,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.23","S":2,"TS":[0,10,0,0]}]},{"x":24.411,"y":4.82,"w":1.895,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"7.34%20","S":2,"TS":[0,10,0,0]}]},{"x":25.195,"y":4.82,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.491,"y":4.82,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":26.01,"y":5.398,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.232,"y":5.398,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.673,"y":5.547,"w":14.039,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20vitreous%20adhesion0.201","S":2,"TS":[0,10,0,0]}]},{"x":18.687,"y":5.547,"w":4.605,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.05%20to%200.36","S":2,"TS":[0,10,0,0]}]},{"x":24.411,"y":5.547,"w":1.895,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"1.31%20","S":2,"TS":[0,10,0,0]}]},{"x":25.195,"y":5.547,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.491,"y":5.547,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":17.27,"y":6.125,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":17.491,"y":6.125,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"4","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":20.627,"y":6.125,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":20.849,"y":6.125,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"3","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":23.458,"y":6.125,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":23.679,"y":6.125,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"5","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":26.01,"y":6.125,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.232,"y":6.125,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.673,"y":6.273,"w":8.037,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Choroidal%20thickness","S":2,"TS":[0,10,0,0]}]},{"x":15.33,"y":6.273,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":15.67,"y":6.273,"w":1.895,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"7.66%20","S":2,"TS":[0,10,0,0]}]},{"x":16.454,"y":6.273,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":16.75,"y":6.273,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":18.687,"y":6.273,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":19.028,"y":6.273,"w":1.895,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"1.43%20","S":2,"TS":[0,10,0,0]}]},{"x":19.812,"y":6.273,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":20.108,"y":6.273,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":20.978,"y":6.273,"w":1.245,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20to%20","S":2,"TS":[0,10,0,0]}]},{"x":21.515,"y":6.273,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":21.855,"y":6.273,"w":1.895,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"9.92%20","S":2,"TS":[0,10,0,0]}]},{"x":22.643,"y":6.273,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":22.939,"y":6.273,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":24.411,"y":6.273,"w":1.895,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2.77%20","S":2,"TS":[0,10,0,0]}]},{"x":25.195,"y":6.273,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.491,"y":6.273,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":9.673,"y":7,"w":11.119,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Clinical%20factors%20at%20year%20one","S":8,"TS":[0,10,1,0]}]},{"x":26.01,"y":7.577999999999999,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.232,"y":7.577999999999999,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"8","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.673,"y":7.727,"w":4.377,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"(Constant)","S":2,"TS":[0,10,0,0]}]},{"x":15.67,"y":7.727,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.495","S":2,"TS":[0,10,0,0]}]},{"x":18.687,"y":7.727,"w":4.605,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.34%20to%200.65","S":2,"TS":[0,10,0,0]}]},{"x":24.411,"y":7.727,"w":1.895,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"1.33%20","S":2,"TS":[0,10,0,0]}]},{"x":25.195,"y":7.727,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.491,"y":7.727,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":26.01,"y":8.304,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.232,"y":8.304,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.673,"y":8.453,"w":5.977,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20EZ","S":2,"TS":[0,10,0,0]}]},{"x":15.33,"y":8.453,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":15.67,"y":8.453,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.163","S":2,"TS":[0,10,0,0]}]},{"x":18.687,"y":8.453,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":19.028,"y":8.453,"w":4.605,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.35%20to%200.03","S":2,"TS":[0,10,0,0]}]},{"x":24.411,"y":8.453,"w":1.895,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"9.87%20","S":2,"TS":[0,10,0,0]}]},{"x":25.195,"y":8.453,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.491,"y":8.453,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":26.01,"y":9.031,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.232,"y":9.031,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.673,"y":9.18,"w":6.803,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20ELM","S":2,"TS":[0,10,0,0]}]},{"x":15.33,"y":9.18,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":15.67,"y":9.18,"w":2.148,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.255","S":2,"TS":[0,10,0,0]}]},{"x":18.687,"y":9.18,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":19.028,"y":9.18,"w":2.937,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.48%20to%20","S":2,"TS":[0,10,0,0]}]},{"x":20.293,"y":9.18,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":43,"TS":[2,10,0,0]}]},{"x":20.633,"y":9.18,"w":1.668,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.03","S":2,"TS":[0,10,0,0]}]},{"x":24.411,"y":9.18,"w":1.895,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2.79%20","S":2,"TS":[0,10,0,0]}]},{"x":25.195,"y":9.18,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.491,"y":9.18,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":26.01,"y":9.757,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%E2%88%92","S":-1,"TS":[2,7.5500002,0,0]}]},{"x":26.232,"y":9.757,"w":0.48,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"2","S":-1,"TS":[0,7.5500002,0,0]}]},{"x":9.673,"y":9.906,"w":14.039,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Presence%20of%20vitreous%20adhesion0.203","S":2,"TS":[0,10,0,0]}]},{"x":18.687,"y":9.906,"w":4.605,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"0.04%20to%200.37","S":2,"TS":[0,10,0,0]}]},{"x":24.411,"y":9.906,"w":1.895,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"1.85%20","S":2,"TS":[0,10,0,0]}]},{"x":25.195,"y":9.906,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%C3%97","S":43,"TS":[2,10,0,0]}]},{"x":25.491,"y":9.906,"w":1.187,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010","S":2,"TS":[0,10,0,0]}]},{"x":9.477,"y":11.164,"w":3.327,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Table%202.","S":9,"TS":[0,12,1,0]}]},{"x":11.323,"y":11.164,"w":39.738,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Predictors%20of%20four-year%20visual%20outcome%20in%20patients%20treated%20with%20aflibercept%2C%20identified%20with%20stepwise%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":11.789,"w":10.243,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"linear%20regression%20analysis.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":14.227,"w":45.002,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"baseline%20VA.%20Thus%2C%20the%20gap%20between%20the%20groups%20were%20diminished%20but%20could%20never%20be%20filled.%20The%20result%20was%20consist-","S":3,"TS":[0,12,0,0]}]},{"x":15.07,"y":14.66,"w":1.192,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"14%2C","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":15.506,"y":14.66,"w":0.964,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"15","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":14.851,"w":43.571,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"ent%20with%20previous%20studies.%20Patients%20with%20good%20visual%20acuity%20tended%20to%20gain%20less%20vision%20due%20to%20the%20ceiling%20effect%2C%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":15.475999999999999,"w":45.381,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"but%20they%20still%20maintained%20a%20higher%20level%20of%20final%20vision.%20The%20result%20indicates%20the%20importance%20of%20early%20detection%20of%20the%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":16.101,"w":45.005,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"disease%20and%20prompt%20treatment.%20Although%20the%20treatment%20can%20be%20used%20for%20those%20with%20poor%20baseline%20visual%20acuity%2C%20it%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":16.726,"w":30.841,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"is%C2%A0difficult%20to%20achieve%20favorable%20outcomes%20once%20the%20retina%20is%20severely%20impaired.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":17.351,"w":43.565,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Fewer%20number%20of%20injections%20was%20not%20associated%20with%20poor%20visual%20outcome%20in%20the%20present%20cohort.%20Considering%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":17.976,"w":44.82,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"that%20AMD%20is%20a%20chronic%20disease%20and%20the%20anti-VEGF%20therapy%20is%20not%20a%20definitive%20treatment%2C%20we%20expected%20that%20cases%20","S":3,"TS":[0,12,0,0]}]},{"x":30.751,"y":18.41,"w":0.984,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"16","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":18.601,"w":44.150999999999996,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"with%20fewer%20injections%20may%20lose%20vision%20due%20to%20undertreatment%2C%20as%20reported%20in%20a%20previous%20study.%20However%2C%20the%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":19.226,"w":44.952,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"present%20result%2C%20together%20with%20bimodal%20distribution%20of%20required%20injections%2C%20indicated%20that%20a%20certain%20percentage%20of%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":19.851,"w":45.364,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"patients%20were%20able%20to%20retain%20vision%20without%20intensive%20treatment%20once%20the%20active%20phase%20of%20the%20disease%20was%20controlled.%20","S":3,"TS":[0,12,0,0]}]},{"x":24.744,"y":20.285,"w":0.952,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"17","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":28.977,"y":20.285,"w":0.952,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"18","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":20.476,"w":34.545,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"In%20fact%2C%20such%20remission%20was%20also%20observed%20with%20photodynamic%20therapy%20and%20ranibizumab","S":3,"TS":[0,12,0,0]}]},{"x":29.326,"y":20.477,"w":9.197,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":".%20While%20proactive%20treat-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":21.101,"w":44.965,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"ment%2C%20including%20fixed%20and%20treat-and-extend%20regimens%20became%20the%20current%20standard%2C%20these%20protocols%20may%20lead%20to%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":21.726,"w":45.172000000000004,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"overtreatment%20in%20some%20patients.%20Identifying%20good%20responders%20may%20reduce%20the%20treatment%20burden%20of%20patients%2C%20physi-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":22.351,"w":45.313,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"cians%2C%20and%20social%20economy.%20Individualized%20treatment%20protocols%20with%20an%20observation%20period%20may%20be%20useful%20to%20avoid%20","S":3,"TS":[0,12,0,0]}]},{"x":15.497,"y":22.785,"w":0.964,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"19","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":22.976,"w":44.452999999999996,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"over-%20and%20under-treatment.%20On%20the%20other%20hand%2C%20some%20cases%20required%20more%20than%2030%20injections%20in%20four%20years.%20We%20","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":23.601,"w":45.291,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"sometimes%20applied%20photodynamic%20therapy%20combined%20with%20aflibercept%20(five%20cases%20in%20this%20cohort)%20but%20the%20result%20was%20","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":24.226,"w":45.143,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"not%20consistent.%20Further%20studies%20are%20needed%20to%20establish%20optimal%20treatment%20strategy%20for%20the%20low-%20or%20non-responders.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":24.851,"w":43.205,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Some%20of%20the%20clinical%20findings%20at%20baseline%20or%20at%20year%20one%20were%20associated%20with%20visual%20outcome%20at%20year%20four.%20","S":3,"TS":[0,12,0,0]}]},{"x":9.478,"y":25.476,"w":45.051,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Specifically%2C%20EZ%20and%20ELM%20represented%20good%20indicator%3B%20they%20reflected%20photoreceptor%20integrity%2C%20and%20the%20association%20","S":3,"TS":[0,12,0,0]}]},{"x":21.606,"y":25.91,"w":1.48,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"20%E2%80%93","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":22.147,"y":25.91,"w":0.96,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"22","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.478,"y":26.101,"w":43.372,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"with%20vision%20was%20consistently%20shown%20in%20previous%20studies.%20Meanwhile%2C%20the%20association%20of%20vitreoretinal%20adhesion%20","S":3,"TS":[0,12,0,0]}]},{"x":34.062,"y":26.535,"w":0.97,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"23","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":26.726,"w":44.163999999999994,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"was%20rather%20unexpected.%20While%20the%20presence%20of%20vitreomacular%20adhesion%20was%20associated%20with%20neovascular%20AMD%20","S":3,"TS":[0,12,0,0]}]},{"x":21.484,"y":27.16,"w":0.952,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"24","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.478,"y":27.351,"w":44.689,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"and%20the%20negative%20effect%20on%20visual%20outcome%20was%20reported%2C%20the%20CATT%20study%20subanalysis%20showed%20no%20association%20with%20","S":3,"TS":[0,12,0,0]}]},{"x":12.923,"y":27.785,"w":0.974,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"25","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":27.976,"w":32.884,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"visual%20outcome.%20Considering%20the%20small%20number%20of%20cases%20with%20vitreous%20adhesion%20(n","S":3,"TS":[0,12,0,0]}]},{"x":28.376,"y":27.977,"w":0.234,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":28.42,"y":27.977,"w":0.778,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"%3D","S":44,"TS":[2,12,0,0]}]},{"x":28.86,"y":27.977,"w":10.257,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2014)%2C%20the%20result%20should%20be%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":28.601,"w":44.84,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"interpreted%20with%20some%20reservation.%20Thick%20Choroid%20at%20baseline%20was%20also%20associated%20with%20better%20visual%20outcome%20as%20","S":3,"TS":[0,12,0,0]}]},{"x":13.846,"y":29.035,"w":0.958,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"26","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":29.226,"w":44.743,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"previously%20reported.%20Difference%20in%20choroidal%20and%20choriocapillaris%20blood%20supply%20was%20suggested%20as%20a%20reason%20for%20the%20","S":3,"TS":[0,12,0,0]}]},{"x":11.098,"y":29.66,"w":0.96,"clr":35,"sw":0.2955625,"A":"left","R":[{"T":"26","S":-1,"TS":[0,8.8499999,0,0]}]},{"x":9.477,"y":29.851,"w":16.561,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"finding%20but%20the%20theory%20is%20yet%20to%20be%20proven.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":30.476,"w":43.831,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"The%20present%20study%20has%20several%20limitations%20including%20relatively%20small%20number%20of%20patients%20and%20considerable%20drop-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":31.101,"w":45.091,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"out%20despite%20that%20last%20observation%20carried%20forward%20analysis%20suggested%20that%20dropout%20did%20not%20bias%20the%20result%20critically.%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":31.726,"w":45.5,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Treatment%20outcome%20according%20to%20CNV%20subtypes%20was%20not%20significantly%20different%20but%20this%20can%20be%20due%20to%20small%20sample%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":32.351,"w":44.925,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"size%20as%20well.%20The%20finding%20should%20be%20confirmed%20in%20larger%20cohort%20with%20multi%20ethnicities.%20In%20addition%2C%20the%20treatment%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":32.976,"w":45.421,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"protocol%20after%20the%20first%20year%20was%20at%20physicians%E2%80%99%20discretion.%20While%20the%20result%20would%20reflect%20real-world%20outcome%2C%20more%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":33.601,"w":36.839,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"controlled%20study%20is%20needed%20to%20confirm%20scientifically%20robust%20evidence%20of%20the%20treatment%20efficacy.","S":3,"TS":[0,12,0,0]}]},{"x":10.227,"y":34.226,"w":43.764,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"In%20conclusion%2C%20we%20showed%20favorable%20four-year%20outcome%20of%20aflibercept%20treatment%20in%20patients%20with%20neovascular%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":34.851,"w":44.964,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"AMD.%20After%20one%20year%20of%20a%20fixed%20regimen%20protocol%2C%20some%20patients%20required%20fewer%20injections%20while%20others%20needed%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":35.476,"w":44.742,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"continuous%20injections.%20The%20presence%20of%20ELM%20and%20the%20absence%20of%20vitreous%20adhesion%20were%20positive%20indicators%20of%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":36.101,"w":41.962,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"vision%20in%20the%20long%20term.%20The%20present%20result%20would%20provide%20practical%20information%20to%20physicians%20in%20this%20field.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":37.477,"w":4.778,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"References","S":-1,"TS":[0,15,1,0]}]},{"x":9.472,"y":38.008,"w":0.941,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%201.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.035,"y":38.008,"w":5.681,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Congdon%2C%20N.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.773,"y":38.008,"w":34.121,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"et%20al.%20Causes%20and%20prevalence%20of%20visual%20impairment%20among%20adults%20in%20the%20United%20States.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":28.702,"y":38.008,"w":7.027,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"Arch%20Ophthalmol%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":31.898000000000003,"y":38.008,"w":1.506,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"122","S":-1,"TS":[0,10.5,1,0]}]},{"x":32.604,"y":38.008,"w":4.102,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20477%E2%80%93485%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.227,"y":38.539,"w":2.84,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"(2004).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.467,"y":39.07,"w":0.9349999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%202.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.029,"y":39.07,"w":30.904,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Jager%2C%20R.%20D.%2C%20Mieler%2C%20W.%20F.%20%26%20Miller%2C%20J.%20W.%20Age-related%20macular%20degeneration.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":24.467,"y":39.07,"w":5.257,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"N%20Engl%20J%20Med","S":-1,"TS":[0,10.5,0,0]}]},{"x":26.594,"y":39.07,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"358","S":-1,"TS":[0,10.5,1,0]}]},{"x":26.899,"y":39.07,"w":8.109,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20%2C%202606%E2%80%932617%20(2008).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.476,"y":39.601,"w":0.959,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%203.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.039,"y":39.601,"w":5.847,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Singer%2C%20M.%20A.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.855,"y":39.601,"w":46.251,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"et%20al.%20HORIZON%3A%20an%20open-label%20extension%20trial%20of%20ranibizumab%20for%20choroidal%20neovascularization%20secondary%20to%20age-","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.227,"y":40.132,"w":18.158,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"related%20macular%20degeneration.%20Ophthalmology","S":-1,"TS":[0,10.5,0,0]}]},{"x":18.705,"y":40.132,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":18.801,"y":40.132,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"119","S":-1,"TS":[0,10.5,1,0]}]},{"x":19.504,"y":40.132,"w":7.882,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%201175%E2%80%931183%20(2012).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.49,"y":40.663,"w":0.995,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%204.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.052,"y":40.663,"w":51.945,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Rofagha%2C%20S.%2C%20Bhisitkul%2C%20R.%20B.%2C%20Boyer%2C%20D.%20S.%2C%20Sadda%2C%20S.%20R.%20%26%20Zhang%2C%20K.%20Seven-year%20outcomes%20in%20ranibizumab-treated%20patients%20in%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.227,"y":41.194,"w":38.592999999999996,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"ANCHOR%2C%20MARINA%2C%20and%20HORIZON%3A%20a%20multicenter%20cohort%20study%20(SEVEN-UP).%20Ophthalmology","S":-1,"TS":[0,10.5,0,0]}]},{"x":28.158,"y":41.194,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":28.254,"y":41.194,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"120","S":-1,"TS":[0,10.5,1,0]}]},{"x":28.957,"y":41.194,"w":7.882,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%202292%E2%80%932299%20(2013).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.461,"y":41.725,"w":0.9319999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%205.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.023,"y":41.725,"w":6.575,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Maguire%2C%20M.%20G.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":13.155,"y":41.725,"w":46.229,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"et%20al.%20Five-year%20outcomes%20with%20anti-vascular%20endothelial%20growth%20factor%20treatment%20of%20neovascular%20age-related%20macular%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.227,"y":42.257,"w":40.068999999999996,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"degeneration%3A%20The%20comparison%20of%20age-related%20cmcular%20degeneration%20treatments%20trials.%20Ophthalmology","S":-1,"TS":[0,10.5,0,0]}]},{"x":28.852,"y":42.257,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":28.947,"y":42.257,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"123","S":-1,"TS":[0,10.5,1,0]}]},{"x":29.65,"y":42.257,"w":7.882,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%201751%E2%80%931761%20(2016).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.466,"y":42.788,"w":0.9349999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%206.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.029,"y":42.788,"w":23.501,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Stewart%2C%20M.%20W.%2C%20Grippon%2C%20S.%20%26%20Kirkpatrick%2C%20P.%20Aflibercept.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":21.04,"y":42.788,"w":8.584,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"Nat%20Rev%20Drug%20Discov%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":24.783,"y":42.788,"w":1,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"11","S":-1,"TS":[0,10.5,1,0]}]},{"x":25.251,"y":42.788,"w":6.922,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20269%E2%80%93270%20(2012).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.466,"y":43.319,"w":0.875,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%207.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.028,"y":43.319,"w":4.37,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Heier%2C%20J.%20S.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.145,"y":43.319,"w":33.042,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"et%20al.%20Intravitreal%20aflibercept%20(VEGF%20trap-eye)%20in%20wet%20age-related%20macular%20degeneration.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":27.472,"y":43.319,"w":5.937,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"Ophthalmology%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":30.179,"y":43.319,"w":1.44,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"119","S":-1,"TS":[0,10.5,1,0]}]},{"x":30.854,"y":43.319,"w":7.502,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%202537%E2%80%932548%20(2012).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.46,"y":43.85,"w":0.9199999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%208.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.023,"y":43.85,"w":8.450999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Schmidt-Erfurth%2C%20U.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":14.052,"y":43.85,"w":44.23,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"et%20al.%20Intravitreal%20aflibercept%20injection%20for%20neovascular%20age-related%20macular%20degeneration%3A%20ninety-six-week%20results%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.226,"y":44.381,"w":14.55,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"of%20the%20VIEW%20studies.%20Ophthalmology","S":-1,"TS":[0,10.5,0,0]}]},{"x":17.017,"y":44.381,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":17.113,"y":44.381,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"121","S":-1,"TS":[0,10.5,1,0]}]},{"x":17.816,"y":44.381,"w":6.922,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20193%E2%80%93201%20(2014).","S":-1,"TS":[0,10.5,0,0]}]},{"x":2.3,"y":47.015,"w":5.514,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"Scientific%20","S":-1,"TS":[0,11,0,0]}]},{"x":5.048,"y":47.015,"w":3.429,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"RepoR","S":-1,"TS":[0,11,1,0]}]},{"x":6.762,"y":47.015,"w":1.255,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"ts","S":-1,"TS":[0,11,1,0]}]},{"x":7.37,"y":47.015,"w":7.835999999999999,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20%20%20%20%20%20%20%20%20%20(2019)%209%3A3620%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.268,"y":47.015,"w":0.627,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.572,"y":47.015,"w":18.416,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"https%3A%2F%2Fdoi.org%2F10.1038%2Fs41598-019-39995-5","S":-1,"TS":[2,11,0,0]}]},{"x":34.087,"y":47.014,"w":0.524,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"6","S":-1,"TS":[0,13,0,0]}]}],"Fields":[],"Boxsets":[]},{"Width":37.205,"Height":48.898,"HLines":[{"x":2.54,"y":47.034,"w":0.45,"l":32.125,"oc":"#000000"}],"VLines":[],"Fills":[{"x":23.91,"y":0.537,"w":10.734,"h":1.113,"oc":"#838f97"},{"x":0,"y":-0.531,"w":37.736,"h":1.152,"oc":"#838f97"},{"x":0,"y":-0.531,"w":37.736,"h":2.339,"oc":"#838f97"},{"x":9.733,"y":37.045,"w":2.593,"h":0.885,"oc":"#c2c4c6"},{"x":9.727,"y":37.034,"w":2.61,"h":0.914,"oc":"#000000"}],"Texts":[{"x":2.29,"y":0.6539999999999999,"w":15.863,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports%2F","S":-1,"TS":[0,13,0,0]}]},{"x":24.108,"y":0.6419999999999999,"w":15.543,"clr":1,"sw":0.26040625,"A":"left","R":[{"T":"www.nature.com%2Fscientificreports","S":-1,"TS":[0,13.25,0,0]}]},{"x":9.472,"y":2.687,"w":0.944,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%209.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.034,"y":2.687,"w":6.472,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Kawashima%2C%20Y.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":13.142,"y":2.687,"w":46.152,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"et%20al.%20Effects%20of%20aflibercept%20for%20ranibizumab-resistant%20neovascular%20age-related%20macular%20degeneration%20and%20polypoidal%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.227,"y":3.219,"w":23.524,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"choroidal%20vasculopathy.%20Graefes%20Arch%20Clin%20Exp%20Ophthalmol","S":-1,"TS":[0,10.5,0,0]}]},{"x":21.19,"y":3.219,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":21.123,"y":3.219,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"253","S":-1,"TS":[0,10.5,1,0]}]},{"x":21.826,"y":3.219,"w":7.882,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%201471%E2%80%931477%20(2015).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.461,"y":3.75,"w":1.415,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2010.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.024,"y":3.75,"w":53.032999999999994,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Seguin-Greenstein%2C%20S.%2C%20Lightman%2C%20S.%20%26%20Tomkins-Netzer%2C%20O.%20A%20meta-analysis%20of%20studies%20evaluating%20visual%20and%20anatomical%20outcomes%20in%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.227,"y":4.281,"w":52.422,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"patients%20with%20treatment%20resistant%20neovascular%20age-related%20macular%20degeneration%20following%20switching%20to%20treatment%20with%20aflibercept.%20J%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.227,"y":4.812,"w":4.8950000000000005,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"Ophthalmol%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.52,"y":4.812,"w":2,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"2016","S":-1,"TS":[0,10.5,1,0]}]},{"x":13.457,"y":4.812,"w":6.882,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%204095852%20(2016).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.369,"y":5.343,"w":1.483,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2011.","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.931,"y":5.343,"w":3.002,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Oishi%2C%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":11.529,"y":5.343,"w":2.902,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"A.%20et%20al","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.918,"y":5.343,"w":46.144,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":".%20One%20year%20result%20of%20aflibercept%20treatment%20on%20age-related%20macular%20degeneration%20and%20predictive%20factors%20for%20visual%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.227,"y":5.874,"w":10.718,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"outcome.%20Am%20J%20Ophthalmol","S":-1,"TS":[0,10.5,0,0]}]},{"x":15.264,"y":5.874,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":15.359,"y":5.874,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"159","S":-1,"TS":[0,10.5,1,0]}]},{"x":16.062,"y":5.874,"w":9.015,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20853%E2%80%93860.e851%20(2015).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.374,"y":6.405,"w":1.431,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2012.","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.937,"y":6.405,"w":4.017,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Hata%2C%20M.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":11.975,"y":6.405,"w":48.471000000000004,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"et%20al.%20Incidence%20and%20causes%20of%20vision%20loss%20during%20aflibercept%20treatment%20for%20neovascular%20age-related%20macular%20degeneration%3A%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.227,"y":6.936,"w":10.693,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"one-year%20follow-up.%20Retina","S":-1,"TS":[0,10.5,0,0]}]},{"x":15.175,"y":6.936,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":15.271,"y":6.936,"w":1,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"37","S":-1,"TS":[0,10.5,1,0]}]},{"x":15.739,"y":6.936,"w":7.882,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%201320%E2%80%931328%20(2017).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.368,"y":7.4670000000000005,"w":1.483,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2013.","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.931,"y":7.4670000000000005,"w":5.204,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Wakazono%2C%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.561,"y":7.4670000000000005,"w":2.8280000000000003,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"T.%20et%20al","S":-1,"TS":[0,10.5,0,0]}]},{"x":13.808,"y":7.4670000000000005,"w":44.375,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":".%20Recurrence%20of%20Choroidal%20Neovascularization%20Lesion%20Activity%20after%20Aflibercept%20Treatment%20for%20Age-Related%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.227,"y":7.997999999999999,"w":12.055,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Macular%20Degeneration.%20Retina","S":-1,"TS":[0,10.5,0,0]}]},{"x":15.837,"y":7.997999999999999,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":15.933,"y":7.997999999999999,"w":1,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"37","S":-1,"TS":[0,10.5,1,0]}]},{"x":16.402,"y":7.997999999999999,"w":7.882,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%202062%E2%80%932068%20(2017).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.48,"y":8.53,"w":1.463,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2014.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.043,"y":8.53,"w":52.39,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Williams%2C%20T.%20A.%20%26%20Blyth%2C%20C.%20P.%20Outcome%20of%20ranibizumab%20treatment%20in%20neovascular%20age%20related%20macula%20degeneration%20in%20eyes%20with%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.226,"y":9.061,"w":19.846,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"baseline%20visual%20acuity%20better%20than%206%2F12.%20Eye%20(Lond)","S":-1,"TS":[0,10.5,0,0]}]},{"x":19.454,"y":9.061,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":19.521,"y":9.061,"w":1,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"25","S":-1,"TS":[0,10.5,1,0]}]},{"x":19.99,"y":9.061,"w":7.882,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%201617%E2%80%931621%20(2011).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.461,"y":9.592,"w":1.331,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2015.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.023,"y":9.592,"w":52.969,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Writing%20Committee%20for%20the%20UK%20Age-Related%20Macular%20Degeneration%20EMR%20Users%20Group.%C2%A0The%20neovascular%20age-related%20macular%20degeneration%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.226,"y":10.123,"w":37.89,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"database%3A%20multicenter%20study%20of%2092%20976%20ranibizumab%20injections%3A%20report%201%3A%20visual%20acuity.%20Ophthalmology","S":-1,"TS":[0,10.5,0,0]}]},{"x":27.787,"y":10.123,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":27.873,"y":10.123,"w":1.44,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"121","S":-1,"TS":[0,10.5,1,0]}]},{"x":28.548,"y":10.123,"w":7.502,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%201092%E2%80%931101%20(2014).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.471,"y":10.654,"w":1.431,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2016.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.034,"y":10.654,"w":4.837,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Holz%2C%20F.%20G.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.37,"y":10.654,"w":47.72,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"et%20al.%20Multi-country%20real-life%20experience%20of%20anti-vascular%20endothelial%20growth%20factor%20therapy%20for%20wet%20age-related%20macular%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.226,"y":11.185,"w":12.055,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"degeneration.%20Br%20J%20Ophthalmol","S":-1,"TS":[0,10.5,0,0]}]},{"x":15.850999999999999,"y":11.185,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":15.947,"y":11.185,"w":1,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"99","S":-1,"TS":[0,10.5,1,0]}]},{"x":16.416,"y":11.185,"w":6.922,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20220%E2%80%93226%20(2015).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.475,"y":11.716,"w":1.447,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2017.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.038,"y":11.716,"w":52.474,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Potter%2C%20M.%20J.%20%26%20Szabo%2C%20S.%20M.%20Recurrence%20of%20choroidal%20neovascularisation%20after%20photodynamic%20therapy%20in%20patients%20with%20age-related%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.226,"y":12.247,"w":15.556999999999999,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"macular%20degeneration.%20Br%20J%20Ophthalmol","S":-1,"TS":[0,10.5,0,0]}]},{"x":17.484,"y":12.247,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":17.579,"y":12.247,"w":1,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"91","S":-1,"TS":[0,10.5,1,0]}]},{"x":18.048,"y":12.247,"w":6.922,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20753%E2%80%93756%20(2007).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.369,"y":12.778,"w":1.471,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2018.","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.931,"y":12.778,"w":2.978,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Oishi%2C%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":11.515,"y":12.778,"w":2.878,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"A.%20et%20al","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.887,"y":12.778,"w":44.401,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":".%20Remission%20and%20dropout%20rate%20of%20anti-VEGF%20therapy%20for%20age-related%20macular%20degeneration.%20Eur%20J%20Ophthalmol","S":-1,"TS":[0,10.5,0,0]}]},{"x":33.706,"y":12.778,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":33.825,"y":12.778,"w":1.026,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"21","S":-1,"TS":[0,10.5,1,0]}]},{"x":34.306,"y":12.778,"w":0.455,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.225,"y":13.309,"w":6.467,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"777%E2%80%93782%20(2011).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.478,"y":13.84,"w":1.463,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2019.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.041,"y":13.84,"w":52.333,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Mantel%2C%20I.%2C%20Niderprim%2C%20S.%20A.%2C%20Gianniou%2C%20C.%2C%20Deli%2C%20A.%20%26%20Ambresin%2C%20A.%20Reducing%20the%20clinical%20burden%20of%20ranibizumab%20treatment%20for%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.225,"y":14.372,"w":40.906,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"neovascular%20age-related%20macular%20degeneration%20using%20an%20individually%20planned%20regimen.%20Br%20J%20Ophthalmol","S":-1,"TS":[0,10.5,0,0]}]},{"x":29.239,"y":14.372,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":29.335,"y":14.372,"w":1,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"98","S":-1,"TS":[0,10.5,1,0]}]},{"x":29.804,"y":14.372,"w":7.882,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%201192%E2%80%931196%20(2014).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.367,"y":14.903,"w":1.479,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2020.","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.93,"y":14.903,"w":4.114,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Hayashi%2C%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.047,"y":14.903,"w":2.969,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"H.%20et%20al","S":-1,"TS":[0,10.5,0,0]}]},{"x":13.443,"y":14.903,"w":45.095,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":".%20Association%20between%20foveal%20photoreceptor%20integrity%20and%20visual%20outcome%20in%20neovascular%20age-related%20macular%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.226,"y":15.434000000000001,"w":12.561,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"degeneration.%20Am%20J%20Ophthalmol","S":-1,"TS":[0,10.5,0,0]}]},{"x":16.082,"y":15.434000000000001,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":16.177,"y":15.434000000000001,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"148","S":-1,"TS":[0,10.5,1,0]}]},{"x":16.88,"y":15.434000000000001,"w":7.574,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%2083%E2%80%9389%20e81%20(2009).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.371,"y":15.965,"w":1.443,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2021.","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.934,"y":15.965,"w":4.089,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Oishi%2C%20A.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.019,"y":15.965,"w":46.096000000000004,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"et%20al.%20The%20significance%20of%20external%20limiting%20membrane%20status%20for%20visual%20acuity%20in%20age-related%20macular%20degeneration.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":33.482,"y":15.965,"w":2.115,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"Am%20J%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.225,"y":16.496,"w":4.8950000000000005,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"Ophthalmol%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.517,"y":16.496,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"150","S":-1,"TS":[0,10.5,1,0]}]},{"x":13.22,"y":16.496,"w":7.574,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%2027%E2%80%9332%20e21%20(2010).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.47,"y":17.027,"w":1.423,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2022.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.032,"y":17.027,"w":52.498,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Sayanagi%2C%20K.%2C%20Sharma%2C%20S.%20%26%20Kaiser%2C%20P.%20K.%20Photoreceptor%20status%20after%20antivascular%20endothelial%20growth%20factor%20therapy%20in%20exudative%20age-","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.225,"y":17.558,"w":18.53,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"related%20macular%20degeneration.%20Br%20J%20Ophthalmol","S":-1,"TS":[0,10.5,0,0]}]},{"x":18.85,"y":17.558,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":18.945,"y":17.558,"w":1,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"93","S":-1,"TS":[0,10.5,1,0]}]},{"x":19.414,"y":17.558,"w":6.922,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20622%E2%80%93626%20(2009).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.367,"y":18.089,"w":1.475,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2023.","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.93,"y":18.089,"w":3.139,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Krebs%2C%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":11.589,"y":18.089,"w":2.536,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"I.%20et%20al","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.795,"y":18.089,"w":46.35,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":".%20Posterior%20vitreomacular%20adhesion%3A%20a%20potential%20risk%20factor%20for%20exudative%20age-related%20macular%20degeneration%3F%20Am%20J%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.225,"y":18.62,"w":4.8950000000000005,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"Ophthalmol%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.517,"y":18.62,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"144","S":-1,"TS":[0,10.5,1,0]}]},{"x":13.22,"y":18.62,"w":6.922,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20741%E2%80%93746%20(2007).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.475,"y":19.151,"w":1.451,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2024.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.038,"y":19.151,"w":52.089999999999996,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Lee%2C%20S.%20J.%20%26%20Koh%2C%20H.%20J.%20Effects%20of%20vitreomacular%20adhesion%20on%20anti-vascular%20endothelial%20growth%20factor%20treatment%20for%20exudative%20age-","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.225,"y":19.682,"w":18.158,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"related%20macular%20degeneration.%20Ophthalmology","S":-1,"TS":[0,10.5,0,0]}]},{"x":18.703,"y":19.682,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":18.798,"y":19.682,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"118","S":-1,"TS":[0,10.5,1,0]}]},{"x":19.502,"y":19.682,"w":6.922,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%20101%E2%80%93110%20(2011).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.485,"y":20.214,"w":1.487,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2025.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.048,"y":20.214,"w":5.579,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Ciulla%2C%20T.%20A.%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.756,"y":20.214,"w":46.451,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"et%20al.%20Influence%20of%20the%20vitreomacular%20interface%20on%20treatment%20outcomes%20in%20the%20comparison%20of%20age-related%20macular%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.225,"y":20.745,"w":18.448,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"degeneration%20treatments%20trials.%20Ophthalmology","S":-1,"TS":[0,10.5,0,0]}]},{"x":18.843,"y":20.745,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":18.938,"y":20.745,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"122","S":-1,"TS":[0,10.5,1,0]}]},{"x":19.641,"y":20.745,"w":7.882,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%201203%E2%80%931211%20(2015).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.459,"y":21.276,"w":1.407,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2026.","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.022,"y":21.276,"w":53.404,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Kang%2C%20H.%20M.%2C%20Kwon%2C%20H.%20J.%2C%20Yi%2C%20J.%20H.%2C%20Lee%2C%20C.%20S.%20%26%20Lee%2C%20S.%20C.%20Subfoveal%20choroidal%20thickness%20as%20a%20potential%20predictor%20of%20visual%20outcome%20and%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.225,"y":21.807,"w":51.553999999999995,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"treatment%20response%20after%20intravitreal%20ranibizumab%20injections%20for%20typical%20exudative%20age-related%20macular%20degeneration.%20Am%20J%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":10.225,"y":22.338,"w":4.8950000000000005,"clr":0,"sw":0.2981875,"A":"left","R":[{"T":"Ophthalmol%20","S":-1,"TS":[0,10.5,0,0]}]},{"x":12.517,"y":22.338,"w":1.5,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"157","S":-1,"TS":[0,10.5,1,0]}]},{"x":13.22,"y":22.338,"w":7.882,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%2C%201013%E2%80%931021%20(2014).","S":-1,"TS":[0,10.5,0,0]}]},{"x":9.477,"y":23.503,"w":8.581,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Acknowledgements","S":-1,"TS":[2,15,1,0]}]},{"x":9.477,"y":24.128,"w":44.976,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"This%20work%20was%20supported%20in%20part%20by%20a%20grant-in-aid%20for%20scientific%20research%20(No.%2017H06820)%20from%20the%20Japan%20Society%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":24.753,"w":45.527,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"for%20the%20Promotion%20of%20Science%2C%20Tokyo%2C%20Japan%2C%20and%20the%20Innovative%20Techno-Hub%20for%20Integrated%20Medical%20Bio-Imaging%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":25.378,"w":45.069,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"of%20the%20Project%20for%20Developing%20Innovation%20Systems%20from%20the%20Ministry%20of%20Education%2C%20Culture%2C%20Sports%2C%20Science%20and%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":26.003,"w":45.039,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Technology%20(MEXT)%2C%20Tokyo%2C%20Japan.%20None%20of%20these%20organizations%20had%20any%20role%20in%20the%20design%20or%20conduct%20of%20this%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":26.628,"w":3.466,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"research.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":27.788,"w":9.185,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Author%20Contributions","S":-1,"TS":[2,15,1,0]}]},{"x":9.477,"y":28.413,"w":45.06,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Design%20of%20the%20work%3A%20A.O.%2C%20S.O.%2C%20K.Y.%20and%20A.T.%3B%20analysis%20of%20data%3A%20K.N.%20and%20A.O.%3B%20acquisition%20of%20data%3A%20A.O.%2C%20M.H.%2C%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":29.038,"w":45.371,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"A.O.%2C%20K.Y.%2C%20M.M.%2C%20H.T.%2C%20N.U.A.%2C%20A.T.%20and%20Y.K.%3B%20drafting%20the%20work%3A%20K.N.%2C%20A.O.%2C%20M.H.%20and%20M.M.%3B%20Critical%20revision%3A%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":29.663,"w":45.649,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"S.O.%2C%20K.Y.%2C%20M.M.%2C%20H.T.%2C%20N.U.A.%2C%20A.T.%2C%20Y.K.%20and%20A.T.%3B%20Final%20approval%3A%20all%20authors.%20Agreement%20to%20be%20accountable%20for%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":30.288,"w":13.747,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"all%20aspects%20of%20the%20work%3A%20all%20authors.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":31.448,"w":9.899,"clr":0,"sw":0.26821875,"A":"left","R":[{"T":"Additional%20Information","S":-1,"TS":[2,15,1,0]}]},{"x":9.477,"y":32.073,"w":11.761,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Supplementary%20information","S":9,"TS":[0,12,1,0]}]},{"x":16.068,"y":32.073,"w":28.553,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20accompanies%20this%20paper%20at%20https%3A%2F%2Fdoi.org%2F10.1038%2Fs41598-019-39995-5","S":3,"TS":[0,12,0,0]}]},{"x":32.077,"y":32.073,"w":0.228,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":".","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":32.979,"w":8.705,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Competing%20Interests%3A","S":9,"TS":[0,12,1,0]}]},{"x":14.407,"y":32.979,"w":35.231,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20A.O.%2C%20S.O.%2C%20K.Y.%20and%20A.T.%20received%20personal%20fee%20from%20Bayer%20(Leverkusen%2C%20Germany)%20and%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":33.604,"w":43.377,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Novartis%20(Basel%2C%20Switzerland).%20Additionaly%2C%20A.O.%20received%20grant%20from%20Novartis%2C%20and%20A.T.%20received%20grant%20from%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":34.229,"w":7.944,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"Bayer%20and%20Novartis.","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":35.135,"w":6.998,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Publisher%E2%80%99s%20note%3A","S":9,"TS":[0,12,1,0]}]},{"x":13.388,"y":35.135,"w":37.075,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20Springer%20Nature%20remains%20neutral%20with%20regard%20to%20jurisdictional%20claims%20in%20published%20maps%20and%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":35.76,"w":9.562,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"institutional%20affiliations.","S":3,"TS":[0,12,0,0]}]},{"x":12.275,"y":36.666,"w":5.473,"clr":0,"sw":0.2825625,"A":"left","R":[{"T":"Open%20Access","S":9,"TS":[0,12,1,0]}]},{"x":15.379,"y":36.666,"w":33.856,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20This%20article%20is%20licensed%20under%20a%20Creative%20Commons%20Attribution%204.0%20International%20","S":3,"TS":[0,12,0,0]}]},{"x":12.265,"y":37.291,"w":39.71,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"License%2C%20which%20permits%20use%2C%20sharing%2C%20adaptation%2C%20distribution%20and%20reproduction%20in%20any%20medium%20or%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":37.916,"w":44.615,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"format%2C%20as%20long%20as%20you%20give%20appropriate%20credit%20to%20the%20original%20author(s)%20and%20the%20source%2C%20provide%20a%20link%20to%20the%20Cre-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":38.541,"w":44.386,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"ative%20Commons%20license%2C%20and%20indicate%20if%20changes%20were%20made.%20The%20images%20or%20other%20third%20party%20material%20in%20this%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":39.166,"w":44.712,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"article%20are%20included%20in%20the%20article%E2%80%99s%20Creative%20Commons%20license%2C%20unless%20indicated%20otherwise%20in%20a%20credit%20line%20to%20the%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":39.791,"w":44.502,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"material.%20If%20material%20is%20not%20included%20in%20the%20article%E2%80%99s%20Creative%20Commons%20license%20and%20your%20intended%20use%20is%20not%20per-","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":40.416,"w":45.177,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"mitted%20by%20statutory%20regulation%20or%20exceeds%20the%20permitted%20use%2C%20you%20will%20need%20to%20obtain%20permission%20directly%20from%20the%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":41.041,"w":38.994,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"copyright%20holder.%20To%20view%20a%20copy%20of%20this%20license%2C%20visit%20http%3A%2F%2Fcreativecommons.org%2Flicenses%2Fby%2F4.0%2F","S":3,"TS":[0,12,0,0]}]},{"x":31.282,"y":41.041,"w":0.228,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":".","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":41.666,"w":0.227,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%20","S":3,"TS":[0,12,0,0]}]},{"x":9.477,"y":42.291,"w":8.8,"clr":0,"sw":0.2955625,"A":"left","R":[{"T":"%C2%A9%20The%20Author(s)%202019","S":3,"TS":[0,12,0,0]}]},{"x":2.3,"y":47.015,"w":5.514,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"Scientific%20","S":-1,"TS":[0,11,0,0]}]},{"x":5.048,"y":47.015,"w":3.429,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"RepoR","S":-1,"TS":[0,11,1,0]}]},{"x":6.762,"y":47.015,"w":1.255,"oc":"#838f97","sw":0.26821875,"A":"left","R":[{"T":"ts","S":-1,"TS":[0,11,1,0]}]},{"x":7.37,"y":47.015,"w":7.835999999999999,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20%20%20%20%20%20%20%20%20%20(2019)%209%3A3620%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.268,"y":47.015,"w":0.627,"clr":0,"sw":0.26040625,"A":"left","R":[{"T":"%20%7C%20","S":-1,"TS":[0,11,0,0]}]},{"x":11.572,"y":47.015,"w":18.416,"clr":0,"sw":0.32553125,"A":"left","R":[{"T":"https%3A%2F%2Fdoi.org%2F10.1038%2Fs41598-019-39995-5","S":-1,"TS":[2,11,0,0]}]},{"x":34.148,"y":47.014,"w":0.428,"oc":"#838f97","sw":0.26040625,"A":"left","R":[{"T":"7","S":-1,"TS":[0,13,0,0]}]}],"Fields":[],"Boxsets":[]}]}